Journal of the Association of Arab Universities for Basic and Applied Sciences (JAAUBAS) http://www.ees.elsevier.com/jaaubas
Aims: The aim of the Journal is to publish scientific research contributions for the development of our societies, exchange experience and findings among scientists and researchers. This aim will surely lead to the development of the colleges of sciences in the Arab Universities. The Journal of the Association of Arab Universities for Basic and Applied Sciences is aimed to be the main communication between the researchers at the Arab Universities and other overseas counterpart colleges. It will assist the academic staff from local and foreign universities and institutions on publishing research results and studies in the basic and applied sciences. This also will make a bridge between the industry, society and the universities. Scientific research will lead universities to provide distinctive higher education that meets the demands of the Arab countries and qualify their forthcoming generation with high class knowledge and science.
Scope: To publish original research and reviews in the field of basic and applied sciences including; Biology, Chemistry, Physics, Mathematics, Operation Research, Statistics, Astronomy, Geology and Engineering.
EDITORIAL BOARD Members of the AAU Colleges of Science Society Editor-In-Chief (EIC) Jazan University, Saudi Lebanese Univ., Lebanon Dr. Hashim A. Al-Sayed, General Secretary of Society of Colleges of Science in Arab Universities, Dean of College of Science, University Arabia Islamic University of Lebanon, of Bahrain. P.O. Box 32038, Kingdom of Bahrain. Princess Nourah bint Lebanon [email protected] Abdulrahman Univ., Saudi Holy Spirit University of Managing Editor (ME) Arabia Kaslik, Lebanon Prof. Waheeb E. Alnaser, Vice President for academic and postgraduate programs, University of Bahrain. P.O. Box 32038, Kuwait University, Kuwait Notre Dame Univ., Lebanon Kingdom of Bahrain. [email protected] Sultan Qaboos Univ., Oman University of Baghdad, Iraq [email protected] Qatar University, Qatar University of Mosul, Iraq Editorial Secretary (ES) Dr. Mohammad El-Hilo, Head of Physics Department, University of University of Sharjah, UAE University of Basrah, Iqaq Bahrain, P.O. Box 32038, Kingdom of Bahrain. University of Jordan, Jordan University of Babylon, Iraq [email protected] The Hashemite Univ., Jordan Al-Nahrain University, Iraq Prof. Shoukry. S. Hassan, Dept. of Mathematics, Univ. of Bahrain, Kingdom of Bahrain. Tafila Technical Univ., Jordan University of Anbar, Iraq Dr. Ahmad Taha,, Dept. of Chemistry, Univ. of Bahrain, Kingdom of Jordan University of Science University of Misan, Iraq Bahrain. and Technology, Jordan University of Thi-Qar, Iraq Dr. Mohamed Bououdina,, Dept. of Physics, Univ. of Bahrain, Kingdom of Bahrain. Yarmouk University, Jordan Al Azhar University, Egypt Philadelphia University, Mansoura University, Egypt International Advisory Editorial Board Members Prof. Farouk El-Baz (Geology), Centre for Remote Sensing, Boston Jordan Assiut University, Egypt Univ., USA. Al-Hussain Bin Talal Univ. of Khartoum, Sudan Prof. Mustafa Amr El-Sayed (Chemistry), Georgia Institute of University, Jordan Sudan University of Science Technology, USA. Al Albayt University, Jordan and Technology, Sudan Prof. Mourad E.H. Ismail (Mathematics), Univ. of Central Florida, USA. An-Najah National Univeristy, Al-Neelain Univ., Sudan Prof. Ahmed Sameh (Computer Science), Minnesota Univ., USA. Palestine Omdurman Univ., Sudan Prof. Munir H. Nayfeh (Physics), Illinois University, USA Birzeit University, Palestine University of Tripoli, Libya Prof. Sultan Abu Orabi (Chemistry), Secretary General of AAU, Jubeyha, Amman, Jordan Al-Aqsa University, Palestine Omar Al-Mukhtar Univ., Libya Prof. Riyad Y. Hamzah (Biochemistry), President of Univ. of Bahrain Islamic Univ.-Gaza, Palestine Distinguished Advisory Member Al Azhar Univ.-Gaza, Prof. Ahmed H. Zewail (Nobel laureate), California Institute of Palestine Technology, USA Al-Aqsa University, Palestine Ethics statements and Copyright Correspondence The author(s) are entirely responsible for accuracy of all statements and data Editor- in-Chief, Journal of the Association of Arab contained in the manuscript, as well as accuracy of all references, and for Universities for Basic and Applied Sciences, College of Science, obtaining and submitting written permission from the author and/or publisher University of Bahrain, P.O. Box 32038, of any previously published manuscript used in the submitted manuscript. Sakhir, Kingdom of Bahrain. Copyrights of the published paper will be transferred to the JAAUBAS upon Tel.: (00973) 17437556 / 17437436/ 17437555 notification of acceptance. Fax: (00973) 17449662 Reprints All rights are reserved: Bahrain Publishing Permission: MAAU 394 A soft electronic copy (PDF file) of the published paper will be sent to the ISSN 1815-3852 corresponding author via e-mail Imprint: University of Bahrain
Journal of the Association of Arab Universities for Basic and Applied Sciences (2016) 21,1–9
University of Bahrain Journal of the Association of Arab Universities for Basic and Applied Sciences www.elsevier.com/locate/jaaubas www.sciencedirect.com
ORIGINAL ARTICLE Facile synthesis and antimicrobial activity of a novel series of 7,8-dihydro-2-(2-oxo-2H- chromen-3-yl)-5-aryl-cyclopenta[b] pyrano-pyrimidine-4,6-5H-dione derivatives catalyzed by reusable silica-bonded N-propyl diethylenetriamine sulfamic acid
Prasanna Nithiya Sudhan, Syed Sheik Mansoor *
Research Department of Chemistry, Bioactive Organic Molecule Synthetic Unit, C. Abdul Hakeem College, Melvisharam 632 509, Tamil Nadu, India
Received 5 June 2014; revised 28 November 2014; accepted 22 December 2014 Available online 21 February 2015
KEYWORDS Abstract An efficient method for the synthesis of a novel series of cyclopenta[b]pyrano Cyclopenta[b]pyrano pyrimidinone derivatives with silica-bonded N-propyl diethylenetriamine sulfamic acid (SBPDSA) pyrimidinones; as catalyst has been achieved by the condensation of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocy- Silica-bonded N-propyl clopenta[b]pyran-3-carbonitrile derivatives and coumarin-3-carboxylic acid under solvent free con- diethylenetriamine sulfamic ditions. Antimicrobial studies showed all the target compounds processing good antibacterial and acid; antifungal activities. Coumarin-3-carboxylic acid; ª 2014 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the Antimicrobial activity CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction pharmacological properties such as anti-inflammatory (Witaicenis et al., 2014), antitumor (Avin et al., 2014), anticancer Coumarins (2-oxo-2H-chromenes) are an old class of com- (Jashari et al., 2014; Zhang et al., 2014), acetylcholinesterase pounds, also known as benzopyranes, comprising a large class (AChE) and butyrylcholinesterase (BuChE) inhibitors of cinnamic acid-derived phenolic compounds found in fungi, (Asadipour et al., 2013), anti-proliferative (Zhao et al., 2014), bacteria and plants, particularly in edible plants from different antibacterial, antifungal and antioxidant (Renuka and Kumar, botanical families. Coumarins and their derivatives have attract- 2013), anti-osteoporotic (Sashidhara et al., 2013) and anti-tuber- ed intense interest in recent years because of their diverse culosis activities (Kawate et al., 2013). A considerable effort has been made for the synthesis of heterocyclic compounds containing coumarin moiety due to * Corresponding author. their wide pharmaceutical importance (Banothu and E-mail address: [email protected] (S. Sheik Mansoor). Bavanthula, 2012; Ghosh and Das, 2012; Augustine et al., Peer review under responsibility of University of Bahrain. http://dx.doi.org/10.1016/j.jaubas.2014.12.001 1815-3852 ª 2014 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 2 P.N. Sudhan, S. Sheik Mansoor
2012; Khoobi et al., 2011; Khan et al., 2011, 2012; Khurana obtained as a white powder. The content of S obtained from and Kumar, 2009). However, these procedures are not entirely elemental analysis showed that typically a loading of satisfactory and suffer from long reaction time or tedious work 0.99 mmol/g H+ was obtained (Rahi et al., 2012). up. Hence, a method using a nonmetallic catalyst is desirable. Therefore, the introduction of new and efficient methods for 2.3. General procedure to synthesis of 2-amino-4-phenyl-5-oxo- this reaction is still necessary. Toward this goal, we were 4,5,6,7-tetrahydrocyclopenta[b] pyran-3-carbonitrile derivatives prompted to explore new methods for the synthesis of hetero- using Alum (KAl(SO4)2.12H2O) (10 mol%) as catalyst cyclic compounds containing coumarin moiety. Silica-bonded N-propyl diethylenetriamine sulfamic acid has A mixture of aldehydes 1 (1 mmol), malononitrile 2 been reported as a novel catalyst for chemoselective synthesis of (1 mmol), cyclopentane-1,3-dione 3 (1 mmol), and powdered 1,1-diacetates (Sefat et al., 2011), and synthesis of a-aminoni- Alum (KAl(SO4)2Æ12H2O) (10 mol%), under solvent-free triles (Rahi et al., 2012). However, to the best of our knowledge, conditions was stirred at 70 C for appropriate time there are no examples on the use of SBPDSA as catalyst for the (Scheme 1). The progress of the reaction was monitored synthesis of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-aryl-cy- by TLC. After completion, the reaction was allowed to cool, clopenta[b]pyrano-pyrimidine-4,6-5H-dione derivatives. ethanol (20 mL) was added and the catalyst was recovered Considering the potential of developing new routes to the syn- to use subsequently by filtration. Concentration of the fil- thesis of heterocyclic compounds containing coumarin moiety due trate and recrystallization of the solid residue from hot etha- to their wide pharmaceutical importance (Ghashang et al., 2013, nol afforded the crystals of 2-amino-4-phenyl-5-oxo-4,5,6,7- 2014a,b), we now describe the synthesis of 7,8-dihydro-2-(2-oxo- tetrahydrocyclopenta[b]pyran-3-carbonitriles in high yield. 2H-chromen-3-yl)-5-phenyl-cyclopenta[b]pyrano-pyrimidine-4,6- The recovered catalyst can be washed consequently with 5H-dione derivatives by the condensation of 2-amino-4-phenyl-5- an aliquot of fresh CH2Cl2 (2 · 10 mL), water and then ace- oxo-4,5,6,7-tetrahydrocyclopenta[b]pyran-3-carbonitrile deriva- tone. After drying, it can be reused without noticeable loss tives and coumarin-3-carboxylic acid using SBPDSA as an efficient of reactivity. Compounds 4a–j were identified by IR, 1H novel catalyst. NMR, 13C NMR, mass and elemental analysis. The synthesis of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahy- drocyclopenta[b]pyran-3-carbonitrile derivatives was achieved 2.4. Spectral data for the synthesized compounds (4a–j) by the condensation of aldehydes 1, malononitrile 2 and cyclopentane-1,3-dione 3, using Alum (KAl(SO4)2Æ12H2O) as 2.4.1. 2-Amino-4-phenyl-5-oxo-4,5,6,7- catalyst under solvent-free conditions (Scheme 1). tetrahydrocyclopenta[b]pyran-3-carbonitrile (4a) IR (KBr, cmÀ1): 3392, 3322, 3220, 2201, 1682, 1604, 1512, 2. Experimental 1 1356, 1061, 683; H NMR (500 MHz, DMSO-d6) d: 2.22– 2.34 (m, 2H, CH2), 2.54–2.65 (m, 2H, CH2), 4.24 (s, 1H, 2.1. Apparatus and analysis CH), 6.66 (s, 2H, NH2), 7.18 (d, J = 7.2 Hz, 2H, ArH), 7.38 13 (m, 3H, ArH) ppm; C NMR (125 MHz, DMSO-d6) d: Chemicals were purchased from Merck, Fluka and Aldrich 26.0, 35.2, 39.0, 49.2, 58.3, 112.0, 119.4, 126.3, 127.3, 129.0, + Chemical Companies. All yields refer to isolated products 144.0, 157.9, 163.0, 195.6 ppm; MS(ESI): m/z 253 (M+H) ; 1 13 unless otherwise stated. H NMR (500 MHz) and C NMR Anal. Calcd for C15H12N2O2: C, 71.42; H, 4.76; N, 11.11%. (125 MHz) spectra were obtained using a Bruker DRX-500 Found: C, 71.36; H, 4.71; N, 11.10%. Avance spectrometer at ambient temperature, using TMS as internal standard. FT-IR spectra were recorded as KBr pellets 2.4.2. 2-Amino-4-(4-methylphenyl)-5-oxo-4,5,6,7- on a Shimadzu spectrometer. Mass spectra were determined on tetrahydrocyclopenta[b]pyran-3-carbonitrile (4b) a Varian-Saturn 2000 GC/MS instrument. Elemental analysis IR (KBr, cmÀ1): 3396, 3320, 3226, 2195, 1665, 1608, 1514, 1 was measured by means of a Perkin Elmer 2400 CHN elemen- 1364, 1036, 798; H NMR (500 MHz, DMSO-d6) d: 2.18 (s, tal analyzer flowchart. 3H, CH3), 2.20–2.34 (m, 2H, CH2), 2.55–2.67 (m, 2H, CH2), 4.19 (s, 1H, CH), 6.74 (s, 2H, NH2), 7.22 (d, J = 7.4 Hz, 2.2. Preparation of silica-bonded N-propyl diethylenetriamine 2H, ArH), 7.40 (d, J = 7.4 Hz, 2H, ArH) ppm; 13C NMR sulfamic acid (SBPDSA) (125 MHz, DMSO-d6) d: 26.7, 35.3, 38.7, 49.4, 58.0, 112.6, 119.2, 126.4, 127.3, 129.3, 143.7, 158.3, 162.9, 196.0 ppm; + The catalyst was prepared as per the previously reported MS(ESI): m/z 267 (M+H) ; Anal. Calcd for C16H14N2O2: method (Sefat et al., 2011). The catalyst SBPDSA was C, 72.18; H, 5.26; N, 10.52%. Found: C, 72.22; H, 5.25; N, 10.50%.
R1
R1 4a H 2.4.3. 2-Amino-4-(4-nitrophenyl)-5-oxo-4,5,6,7- R 1 4b 4-CH3 tetrahydrocyclopenta[b]pyran-3-carbonitrile (4c) Alum 4c 4-NO2 10 mol% O 4d 3-Br À1 CHO CN IR (KBr, cm ): 3400, 3324, 3228, 2206, 1673, 1606, 1522, O 4e 4-Cl 1a-j 70 oC 4f 3-OH 1 1355, 1073, 836; H NMR (500 MHz, DMSO-d6) d: 2.18– Solvent-free O NH 4g 4-OH + NC CN 2 4h 4-N(CH ) 2.27 (m, 2H, CH ), 2.53–2.61 (m, 2H, CH ), 4.22 (s, 1H, 2 4a- j 3 2 2 2 4i 3-CH 3 3 CH), 6.80 (s, 2H, NH ), 7.26 (d, J = 7.0 Hz, 2H, ArH), 7.45 O 4j 3-OCH3 2 (d, J = 7.1 Hz, 2H, ArH) ppm; 13C NMR (125 MHz, Scheme 1 Preparation of various 2-amino-4-phenyl-5-oxo- DMSO-d6) d: 26.4, 35.4, 39.4, 49.1, 57.9, 113.0, 118.9, 125.9, 4,5,6,7-tetrahydrocyclopenta [b]pyran-3-carbonitrile derivatives. 127.3, 128.9, 143.8, 158.5, 163.8, 196.2 ppm; MS(ESI): m/z Synthesis of cyclopenta[b]pyrano pyrimidinone derivatives 3
+ 298 (M+H) ; Anal. Calcd for C15H11N3O4: C, 60.60; H, 3.70; 59.2, 112.9, 118.7, 126.3, 127.3, 129.3, 144.5, 158.0, 163.4, N, 14.14%. Found: C, 60.50; H, 3.66; N, 14.10%. 196.1 ppm; MS(ESI): m/z 296 (M+H)+; Anal. Calcd for C17H17N3O2: C, 69.15; H, 5.76; N, 14.23%. Found: C, 69.07; 2.4.4. 2-Amino-4-(3-bromophenyl)-5-oxo-4,5,6,7-tetrahydrocyc H, 5.71; N, 14.19%. lopenta[b]pyran-3-carbonitrile (4d) IR (KBr, cmÀ1): 3403, 3318, 3212, 2207, 1678, 1611, 1510, 2.4.9. 2-Amino-4-(3-methylphenyl)-5-oxo-4,5,6,7-tetrahydroc 1 yclopenta[b]pyran-3-carbonitrile (4i) 1360, 1074, 845; H NMR (500 MHz, DMSO-d6) d: 2.09– À1 2.18 (m, 2H, CH2), 2.44–2.53 (m, 2H, CH2), 4.26 (s, 1H, IR (KBr, cm ): 3388, 3322, 3222, 2204, 1675, 1607, 1514, 13 1 CH), 6.85 (s, 2H, NH2), 7.31–7.44 (m, 4H, ArH) ppm; C 1362, 1077, 790; H NMR (500 MHz, DMSO-d6) d: 2.12– NMR (125 MHz, DMSO-d6) d: 27.0, 36.0, 38.7, 49.7, 58.6, 2.19 (m, 2H, CH2), 2.24 (s, 3H, CH3), 2.42–2.53 (m, 2H, 113.2, 118.8, 126.3, 127.3, 128.7, 144.4, 158.8, 164.0, CH2), 4.12 (s, 1H, CH), 6.76 (s, 2H, NH2), 7.30–7.45 (m, + 13 195.9 ppm; MS(ESI): m/z 331.9 (M+H) ; Anal. Calcd for 4H, ArH) ppm; C NMR (125 MHz, DMSO-d6) d: 26.4, C15H11BrN2O4: C, 54.40; H, 3.32; N, 8.46%. Found: C, 35.7, 38.3, 50.2, 58.3, 112.9, 118.9, 125.8, 127.3, 128.8, 143.8, 54.42; H, 3.30; N, 8.44%. 157.9, 163.6, 196.0 ppm; MS(ESI): m/z 267 (M+H)+; Anal. Calcd for C16H14N2O2: C, 72.18; H, 5.26; N, 10.52%. Found: 2.4.5. 2-Amino-4-(4-chlorophenyl)-5-oxo-4,5,6,7-tetrahydrocyc C, 72.12; H, 5.22; N, 10.48%. lopenta[b]pyran-3-carbonitrile (4e) IR (KBr, cmÀ1): 3394, 3331, 3214, 2208, 1669, 1600, 1515, 2.4.10. 2-Amino-4-(3-methoxyphenyl)-5-oxo-4,5,6,7-tetrahydro 1 cyclopenta[b]pyran-3-carbonitrile (4j) 1362, 1071, 844; H NMR (500 MHz, DMSO-d6) d: 2.16– À1 2.28 (m, 2H, CH2), 2.51–2.63 (m, 2H, CH2), 4.16 (s, 1H, IR (KBr, cm ): 3405, 3326, 3216, 2195, 1681, 1597, 1523, 1 CH), 6.74 (s, 2H, NH2), 7.25 (d, J = 7.2 Hz, 2H, ArH), 7.38 1355, 1031, 849, 762; H NMR (500 MHz, DMSO-d6) d: 13 (d, J = 7.2 Hz, 2H, ArH) ppm; C NMR (125 MHz, 2.13–2.24 (m, 2H, CH2), 2.38–2.50 (m, 2H, CH2), 3.58 (s, DMSO-d6) d: 26.8, 36.1, 39.4, 49.4, 58.6, 112.8, 119.4, 126.5, 3H, OCH3), 4.17 (s, 1H, CH), 6.69 (s, 2H, NH2), 7.19–7.33 13 127.3, 128.4, 144.0, 158.6, 163.6, 196.1 ppm; MS(ESI): m/z (m, 4H, ArH) ppm; C NMR (125 MHz, DMSO-d6) d: + 287 (M+H) ; Anal. Calcd for C15H11ClN2O2: C, 62.84; H, 27.4, 36.4, 38.7, 49.7, 59.3, 113.5, 118.2, 125.6, 127.3, 129.4, 3.84; N, 9.77%. Found: C, 62.77; H, 3.80; N, 9.75%. 144.0, 158.2, 163.7, 195.8 ppm; MS(ESI): m/z 283 (M+H)+; Anal. Calcd for C16H14N2O3: C, 68.08; H, 4.96; N, 9.92%. 2.4.6. 2-Amino-4-(3-hydroxyphenyl)-5-oxo-4,5,6,7-tetrahydroc Found: C, 68.00; H, 4.94; N, 9.88%. yclopenta[b]pyran-3-carbonitrile (4f) IR (KBr, cmÀ1): 3432, 3390, 3329, 3219, 2196, 1680, 1598, 2.5. General procedure to synthesis of 7,8-dihydro-2-(2-oxo-2H- 1 chromen-3-yl)-5-phenyl-cyclopenta[b]pyrano-pyrimidine-4,6- 1524, 1351, 1066, 856; H NMR (500 MHz, DMSO-d6) d: 5H-dione derivatives using SBPDSA as catalyst 2.11–2.23 (m, 2H, CH2), 2.55–2.66 (m, 2H, CH2), 4.21 (s, 1H, CH), 6.80 (s, 2H, NH2), 7.34–7.49 (m, 4H, ArH), 9.48 13 (s, 1H, OH) ppm; C NMR (125 MHz, DMSO-d6) d: 27.2, A mixture of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydrocy- 35.7, 38.6, 50.0, 59.0, 113.4, 118.8, 125.7, 127.3, 129.0, 143.6, clopenta[b]pyran-3-carbonitrile 4a–j (1 mmol), coumarin-3- 158.4, 163.8, 195.7 ppm; MS(ESI): m/z 269 (M+H)+; Anal. carboxylic acid 5 (1 mmol) and SBPDSA (0.051 g/5 mol%) Calcd for C15H12N2O3: C, 67.16; H, 4.48; N, 10.45%. Found: was heated at 80 C for about 4–6 h (Scheme 2). After comple- C, 67.10; H, 4.44; N, 10.40%. tion of the reaction (TLC), 2 mL of water was added, and the reaction mixture was stirred at room temperature for 20 min. 2.4.7. 2-Amino-4-(4-hydroxyphenyl)-5-oxo-4,5,6,7-tetrahydroc The resulting precipitate was filtered. The crude product was yclopenta[b]pyran-3-carbonitrile (4g) purified by column chromatography (n-hexane/ethyl acetate, IR (KBr, cmÀ1): 3466, 3401, 3333, 3289, 2194, 1677, 1596, 80:20) to provide the pure products. Compounds 6a–j were 1 identified by IR, 1H NMR, 13C NMR, mass and elemental 1525, 1358, 1074, 844; H NMR (500 MHz, DMSO-d6) d: analysis. 2.06–2.14 (m, 2H, CH2), 2.43–2.56 (m, 2H, CH2), 4.27 (s, 1H, CH), 6.82 (s, 2H, NH2), 7.19 (d, J = 7.1 Hz, 2H, ArH), 7.35 (d, J = 7.2 Hz, 2H, ArH), 9.56 (s, 1H, OH) ppm; 13C 2.6. Spectral data for the synthesized compounds (6a–j) NMR (125 MHz, DMSO-d6) d: 26.5, 36.1, 39.3, 50.2, 58.4, 112.7, 118.7, 126.7, 127.3, 129.2, 144.2, 158.4, 163.0, 2.6.1. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-phenyl- 196.2 ppm; MS(ESI): m/z 269 (M+H)+; Anal. Calcd for cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6a) C15H12N2O3: C, 67.16; H, 4.48; N, 10.45%. Found: C, 67.06; IR (KBr, cmÀ1): 3411, 1713, 1659, 1620, 1599, 1211, 1066, 701; H, 4.45; N, 10.43%. 1 H NMR (500 MHz, DMSO-d6) d: 2.04–2.15 (m, 2H, CH2), 2.44–2.56 (m, 2H, CH2), 4.44 (s, 1H, CH), 7.12 (d, 2.4.8. 2-Amino-4-(4-N,N-dimethylaminophenyl)-5-oxo-4,5,6,7- J = 7.2 Hz, 2H, ArH), 7.44–7.51 (m, 3H, ArH), 7.66–7.78 tetrahydrocyclopenta[b]pyran-3-carbonitrile (4h) (m, 4H, ArH), 8.46 (s, 1H, Coumarin), 9.48 (s, 1H, NH) À1 13 IR (KBr, cm ): 3398, 3320, 3210, 2199, 1672, 1604, 1516, ppm; C NMR (125 MHz, DMSO-d6) d: 16.5, 20.3, 26.7, 1 1364, 1033, 855; H NMR (500 MHz, DMSO-d6) d: 2.20– 35.9, 37.2, 100.0, 113.2, 115.9, 118.2, 118.9, 124.9, 129.3, 2.32 (m, 2H, CH2), 2.50–2.61 (m, 2H, CH2), 2.72 (s, 6H, 131.0, 134.0, 136.5, 152.5, 154.6, 156.9, 164.7, 195.4 ppm; + N(CH3)2), 4.29 (s, 1H, CH), 6.78 (s, 2H, NH2), 7.26 (d, MS(ESI): m/z 425 (M+H) ; Anal. Calcd for C25H16N2O5: J = 7.2 Hz, 2H, ArH), 7.41 (d, J = 7.2 Hz, 2H, ArH) ppm; C, 70.75; H, 3.77; N, 6.60%. Found: C, 70.70; H, 3.75; N, 13 C NMR (125 MHz, DMSO-d6) d: 27.2, 37.3, 38.6, 49.6, 6.58%. 4 P.N. Sudhan, S. Sheik Mansoor
R1 R1 O O R1 O SBPDSA 6a H HOOC CN 0.051 g (5 mol%) NH 6b 4-CH3 + 6c 4-NO2 Solvent-free O N 6d 3-Br O NH O O 2 80 oC 6e 4-Cl 4a-j 5 O O 6f 3-OH 6a- j 6g 4-OH 6 h 4-N(CH3)2 6i 3-CH3 SO3H SO3H 6j 3-OCH3 O N N O N H SiO2 Si O SO3H
(SBPDSA)
Scheme 2 Preparation of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-aryl-cyclopenta[b] pyrano-pyrimidine-4,6-5H-diones.
2.6.2. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(4-methy J = 7.2 Hz, 2H, ArH), 7.28 (d, J = 7.2 Hz, 2H, ArH), 7.73– lphenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6b) 7.86 (m, 4H, ArH), 8.38 (s, 1H, Coumarin), 9.50 (s, 1H, 13 IR (KBr, cmÀ1): 3406, 1700, 1660, 1622, 1603, 1205, 1044, 788; NH) ppm; C NMR (125 MHz, DMSO-d6) d: 16.0, 20.0, 1 26.2, 35.9, 37.7, 101.3, 113.9, 115.7, 118.2, 118.8, 124.8, H NMR (500 MHz, DMSO-d6) d: 2.11–2.21 (m, 2H, CH2), 2.28 (s, 3H, CH ), 2.52–2.64 (m, 2H, CH ), 4.50 (s, 1H, CH), 129.3, 130.7, 133.8, 137.0, 153.4, 154.1, 156.7, 164.4, 3 2 + 7.22 (d, J = 7.2 Hz, 2H, ArH), 7.51 (d, J = 7.2 Hz, 2H, 195.4 ppm; MS(ESI): m/z 459.45 (M+H) ; Anal. Calcd for ArH), 7.60–7.77 (m, 4H, ArH), 8.40 (s, 1H, Coumarin), 9.40 C25H15ClN2O5: C, 65.43; H, 3.27; N, 6.11%. Found: C, 13 65.40; H, 3.25; N, 6.10%. (s, 1H, NH) ppm; C NMR (125 MHz, DMSO-d6) d: 16.6, 20.4, 26.5, 35.7, 36.9, 101.0, 113.8, 115.7, 117.9, 118.4, 124.3, 129.3, 130.5, 134.2, 137.0, 153.0, 154.0, 157.1, 163.9, 2.6.6. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(3-hydro 194.9 ppm; MS(ESI): m/z 439 (M+H)+; Anal. Calcd for xyphenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6f) À1 C26H18N2O5: C, 71.23; H, 4.11; N, 6.39%. Found: C, 71.13; IR (KBr, cm ): 3455, 3403, 1698, 1669, 1622, 1596, 1210, 1 H, 4.09; N, 6.36%. 1043, 846; H NMR (500 MHz, DMSO-d6) d: 2.02–2.12 (m, 2H, CH2), 2.33–2.44 (m, 2H, CH2), 4.55 (s, 1H, CH), 7.24– 2.6.3. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(4-nitro 7.46 (m, 4H, ArH), 7.77–7.88 (m, 4H, ArH), 8.42 (s, 1H, phenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6c) Coumarin), 9.52 (s, 1H, NH), 9.66 (s, 1H, OH) ppm; 13C IR (KBr, cmÀ1): 3400, 1704, 1664, 1624, 1605, 1202, 1063, 844; NMR (125 MHz, DMSO-d6) d: 16.4, 20.3, 26.1, 36.4, 38.0, 1 100.5, 113.4, 116.3, 118.2, 118.6, 124.6, 129.3, 130.7, 134.4, H NMR (500 MHz, DMSO-d6) d: 2.16–2.32 (m, 2H, CH2), 2.58–2.70 (m, 2H, CH ), 4.51 (s, 1H, CH), 7.19 (d, 136.4, 153.2, 154.1, 157.1, 164.5, 195.5 ppm; MS(ESI): m/z 2 + J = 7.2 Hz, 2H, ArH), 7.44 (d, J = 7.2 Hz, 2H, ArH), 7.62– 441 (M+H) ; Anal. Calcd for C25H16N2O6: C, 68.18; H, 7.75 (m, 4H, ArH), 8.33 (s, 1H, Coumarin), 9.39 (s, 1H, 3.63; N, 6.36%. Found: C, 68.11; H, 3.60; N, 6.34%. 13 NH) ppm; C NMR (125 MHz, DMSO-d6) d: 16.6, 20.3, 26.6, 36.2, 37.2, 100.2, 113.1, 116.4, 118.4, 118.9, 124.9, 2.6.7. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(4-hydro 129.3, 130.3, 134.3, 136.4, 153.1, 154.0, 156.3, 163.5, xyphenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6g) 194.5 ppm; MS(ESI): m/z 470 (M+H)+; Anal. Calcd for IR (KBr, cmÀ1): 3458, 3410, 1714, 1664, 1625, 1602, 1216, 1 C25H15N3O7: C, 63.96; H, 3.20; N, 8.95%. Found: C, 63.88; 1073, 840; H NMR (500 MHz, DMSO-d6) d: 2.21–2.28 (m, H, 3.20; N, 2.90%. 2H, CH2), 2.49–2.57 (m, 2H, CH2), 4.52 (s, 1H, CH), 7.20 (d, J = 7.2 Hz, 2H, ArH), 7.38 (d, J = 7.2 Hz, 2H, ArH), 2.6.4. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(4-bromo 7.70–7.82 (m, 4H, ArH), 8.50 (s, 1H, Coumarin), 9.43 (s, 1H, phenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6d) NH), 9.72 (s, 1H, OH) ppm; 13C NMR (125 MHz, DMSO- IR (KBr, cmÀ1): 3415, 1699, 1661, 1618, 1600, 1206, 1070, 840; d6) d: 16.6, 19.9, 26.8, 36.3, 38.2, 100.1, 113.3, 116.5, 118.1, 1 118.9, 124.8, 129.3, 130.8, 134.3, 136.4, 153.1, 154.3, 157.5, H NMR (500 MHz, DMSO-d6) d: 2.04–2.12 (m, 2H, CH2), 164.0, 195.8 ppm; MS(ESI): m/z 441 (M+H)+; Anal. Calcd 2.32–2.46 (m, 2H, CH2), 4.46 (s, 1H, CH), 7.25–7.42 (m, 4H, ArH), 7.78–7.90 (m, 4H, ArH), 8.44 (s, 1H, Coumarin), 9.45 for C25H16N2O6: C, 68.18; H, 3.63; N, 6.36%. Found: C, 13 68.20; H, 3.65; N, 6.33%. (s, 1H, NH) ppm; C NMR (125 MHz, DMSO-d6) d: 16.7, 20.4, 26.0, 36.3, 37.1, 100.4, 113.6, 116.0, 118.4, 119.0, 124.8, 129.3, 131.0, 134.2, 136.4, 152.8, 153.8, 156.8, 163.8, 2.6.8. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(4-N,N-dime 194.9 ppm; MS(ESI): m/z 503.9 (M+H)+; Anal. Calcd for thylaminophenyl)-cyclopenta [b]pyrano-pyrimidine-4,6-5H- C25H15BrN2O5: C, 59.65; H, 2.98; N, 5.56%. Found: C, dione (6h) 59.55; H, 2.95; N, 5.54%. IR (KBr, cmÀ1): 3402, 1712, 1661, 1622, 1601, 1213, 1053, 845; 1 H NMR (500 MHz, DMSO-d6) d: 2.15–2.22 (m, 2H, CH2), 2.6.5. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(4-chloro 2.55–2.62 (m, 2H, CH2), 2.68 (s, 6H, N(CH3)2), 4.48 (s, 1H, phenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6e) CH), 7.16 (d, J = 7.2 Hz, 2H, ArH), 7.42 (d, J = 7.2 Hz, IR (KBr, cmÀ1): 3424, 1708, 1658, 1619, 1607, 1208, 1073, 853; 2H, ArH), 7.65–7.79 (m, 4H, ArH), 8.55 (s, 1H, Coumarin), 1 13 H NMR (500 MHz, DMSO-d6) d: 2.18–2.30 (m, 2H, CH2), 9.40 (s, 1H, NH) ppm; C NMR (125 MHz, DMSO-d6) d: 2.62–2.73 (m, 2H, CH2), 4.39 (s, 1H, CH), 7.10 (d, 15.9, 19.9, 26.6, 36.4, 37.0, 100.9, 113.4, 116.0, 118.1, 118.9, Synthesis of cyclopenta[b]pyrano pyrimidinone derivatives 5
124.7, 129.3, 131.2, 134.3, 136.3, 152.8, 153.9, 156.8, 164.3, Table 1 Preparation of various 2-amino-4-phenyl-5-oxo- 194.6 ppm; MS(ESI): m/z 468 (M+H)+; Anal. Calcd for 4,5,6,7-tetrahydrocyclopenta[b]pyran-3-carbonitrile C H N O : C, 69.38; H, 4.49; N, 8.99%. Found: C, 69.31; 27 21 3 5 derivatives.a H, 4.46; N, 8.97%. Entry R1 Product Time (h) Yield (%)b Mp ( C) 2.6.9. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(3-methy 1H 4a 2.0 93 204–206 lphenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6i) 2 4-CH3 4b 2.0 90 206–208 IR (KBr, cmÀ1): 3418, 1703, 1657, 1617, 1607, 1209, 1070, 796; 3 4-NO2 4c 2.0 88 201–203 4 3-Br 4d 1.5 89 220–222 1H NMR (500 MHz, DMSO-d ) d: 2.17–2.29 (m, 2H, CH ), 6 2 5 4-Cl 4e 1.5 90 242–244 2.34 (s, 3H, CH3), 2.52–2.64 (m, 2H, CH2), 4.50 (s, 1H, CH), 6 3-OH 4f 1.5 92 212–214 7.11–7.31 (m, 4H, ArH), 7.73–7.87 (m, 4H, ArH), 8.41 (s, 7 4-OH 4g 2.0 90 228–230 13 1H, Coumarin), 9.38 (s, 1H, NH) ppm; C NMR 8 4-N(CH3)2 4h 2.0 89 236–238 (125 MHz, DMSO-d6) d: 16.2, 20.0, 26.2, 36.1, 37.1, 100.8, 9 3-CH3 4i 1.5 89 198–200 113.7, 115.6, 117.9, 118.7, 124.8, 129.3, 131.4, 135.0, 137.2, 10 3-OCH3 4j 2.0 92 190–192 153.4, 154.1, 156.9, 164.0, 195.5 ppm; MS(ESI): m/z 439 a Reaction conditions: cyclopentane-1,3-dione (1 mmol), aldehy- + (M+H) ; Anal. Calcd for C26H18N2O5: C, 71.23; H, 4.11; de (1 mmol) and malononitrile (1 mmol) in the presence of Alum
N, 6.39%. Found: C, 71.20; H, 4.07; N, 6.33%. (KAl(SO4)2Æ12H2O) (10 mol%) in solvent-free conditions at 70 C. b Isolated yield. 2.6.10. 7,8-Dihydro-2-(2-oxo-2H-chromen-3-yl)-5-(3-metho xyphenyl)-cyclopenta[b]pyrano-pyrimidine-4,6-5H-dione (6j) the amount from 5 to 8 mol% has no effect on the product IR (KBr, cmÀ1): 3406, 1709, 1662, 1626, 1600, 1214, 1029, 847, yield and reaction time (Table 2, entry 8). 769; 1H NMR (500 MHz, DMSO-d ) d: 2.18–2.29 (m, 2H, 6 To expand the generality of this novel catalytic method, CH ), 2.40–2.56 (m, 2H, CH ), 3.66 (s, 3H, OCH ), 4.47 (s, 2 2 3 various cyclopenta[b]pyrano pyrimidinone derivatives 6a–j 1H, CH), 7.18–7.33 (m, 4H, ArH), 7.76–7.90 (m, 4H, ArH), (Scheme 2) were synthesized under the optimized conditions 8.39 (s, 1H, Coumarin), 9.41 (s, 1H, NH) ppm; 13C NMR and the results are presented in Table 3. After completion of (125 MHz, DMSO-d ) d: 16.3, 20.2, 26.3, 35.7, 37.0, 101.2, 6 the reaction the catalyst, SBPDSA was recovered by 114.2, 116.0, 118.3, 118.8, 125.0, 129.3, 131.4, 134.2, 136.4, evaporating the aqueous layer, washed with acetone, dried 152.8, 153.8, 157.4, 166.0, 196.0 ppm; MS(ESI): m/z 455 and reused for subsequent reactions without significant loss (M+H)+; Anal. Calcd for C H N O : C, 68.72; H, 3.96; 26 18 2 6 in its activity (Fig. 1). All the structures of the synthesized N, 6.16%. Found: C, 68.61; H, 3.93; N, 6.15%. compounds 6 were confirmed by their analytical and spectroscopic data. 3. Results and discussion A probable mechanism for the formation of 6a as a model via the condensation reaction is outlined in Scheme 3. Firstly, The synthetic pathway of compounds (6a–j) was achieved via the protonation of coumarin-3-carboxylic acid by SBPDSA as the intermediates 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahydro- a solid acid occurred to form a cation intermediate (a). In con- cyclopenta[b]pyran-3-carbonitrile derivatives (4a–j). These tinuation, the formation of (b) resulting from the amidation of compounds (4a–j) were obtained by the three component (a) with 4a was established. In the next step, the protonation of condensation of aldehydes 1, malononitrile 2 and cyclopen- nitrile group of intermediate (b) following by a cyclo-addition tane-1,3-dione 3 using Alum (KAl(SO4)2Æ12H2O) (10 mol%), reaction occurred to form the intermediate (c). In continuation À under solvent-free conditions (Scheme 1). Due to its mild the addition reaction of -SO3 followed by ring opening of the and reusable catalytic activity for the synthesis of pyran (c) to the intermediate (d) and (e) followed by ring closure of derivatives (Rajguru et al., 2013), we opted to use Alum intermediate (e) results in the formation of intermediate (f) [KAl(SO4)2Æ12H2O] as a non-toxic catalyst. The aromatic alde- that converts to the (6a) as product by the de-protonation hydes 1 bearing electron-withdrawing and electron donating reaction. Interestingly, the formation of compound 6a, groups were found to be equally effective to produce 2- obtained from the condensation of coumarin-3-carboxylic acid amino-4H-pyrans 4a–j in very good yields (Table 1). with 4a, confirms the mechanism of the reaction which was After the synthesis of 2-amino-4-phenyl-5-oxo-4,5,6,7-te- rarely described in the literature as Dimroth rearrangement trahydrocyclopenta[b]pyran-3-carbonitrile derivatives 4,we (Foucourt et al., 2010; Dimroth, 1909). have synthesized compounds 6. To optimize the reaction The possibility of recycling the catalyst was examined using conditions, the effect of catalyst loading was investigated the condensation reaction of compound 4a with coumarin-3- between compound 4a and coumarin-3-carboxylic acid. The carboxylic acid 5 in the optimized conditions. The catalyst reaction was carried out under neat conditions at 80 C with- was recovered from the aqueous phase (filtration), washed out and with different acid catalysts (cellulose sulfuric acid, with acetone, dried and re-used for subsequent reactions with- silica sulfuric acid, sulfamic acid, SBPDSA each 5 mol%). out loss of activity and efficiency. The recycled catalyst could The maximum yield was obtained using SBPDSA. It can be be reused five times without any additional treatment or appre- seen that the reaction did not proceed even after 12 h in the ciable reduction in catalytic activity (Fig. 1). absence of this catalyst (Table 2, entry 1). Although a lower X-ray diffraction (XRD) for SBPDSA using powder X-ray catalyst loading of 3 or 2 mol% accomplished this condensa- diffraction measurements was performed using Advance tion, 5 mol% of SBPDSA was optimal in terms of reaction diffractometer made by Bruker AXS company in Germany. time and isolated yield (Table 2, entries 5 and 6). Increasing Scans were taken with a 2h step size of 0.04 and a counting 6 P.N. Sudhan, S. Sheik Mansoor
Table 2 Preparation of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-phenyl-cyclopenta[b] pyrano-pyrimidine-4,6-5H-dione: Effect of catalyst.a Entry Catalyst Amount of catalyst (mol%) Time (h) Yield (%)b 1 None 0 12.0 Trace 2 Cellulose sulfuric acid 5 6.0 70 3 Silica sulfuric acid 5 6.0 73 4 Sulfamic acid 5 8.0 59 5 SBPDSA 5 (0.051 g) 4.0 90 6 SBPDSA 8 (0.081 g) 4.0 90 7 SBPDSA 3 (0.031 g) 4.0 77 8 SBPDSA 2 (0.021 g) 4.0 69 a Reaction conditions: 4a (1 mmol) and coumarin-3-carboxylic acid (1 mmol) at 80 C. b Isolated yield.
Table 3 Preparation of various 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-aryl-cyclopenta [b]pyrano-pyrimidine-4,6-5H-dione derivatives.a Entry Compound 4 Product Time (h) Yield (%)b Mp ( C) 1 4a 6a 4.0 90 266–268 2 4b 6b 4.0 88 224–226 3 4c 6c 3.5 91 258–260 4 4d 6d 3.5 91 234–236 5 4e 6e 3.5 90 238–240 6 4f 6f 4.0 90 246–248 7 4g 6g 4.0 92 254–256 8 4h 6h 4.0 88 262–264 9 4i 6i 4.0 89 244–246 10 4j 6j 4.0 89 272–274 a Reaction conditions: 4a–j (1 mmol), and coumarin-3-carboxylic acid (1 mmol) in the presence of SBPDSA (5 mol%) at 80 C. b Isolated yield.
94 in Fig. 2 no significant change in the structure of catalyst Recycleability of SBPDSA was observed during the reaction. 92 90% 3.1. Biological evaluations 90 88% Variously substituted on the aromatic ring, the compounds 88 87% 6a–j may be useful in understanding the influence of steric 86 and electronic effects on biological activity. They were tested Yield (%) 85% for their antibacterial and antifungal activity at different con- 84% 84 centrations in DMSO. Ciprofloxacin and Amphotericin-B were used as the positive control drugs for antibacterial and 82 antifungal tests, respectively. Inoculums of the bacterial and fungal cultures were also prepared. The minimum concentra- 80 tion at which no growth was observed was taken as the 12345 minimum inhibitory concentration (MIC) value. Number of Runs 3.2. Antibacterial activity Figure 1 Recycling of catalyst SBPDSA for the synthesis of 7,8- dihydro-2-(2-oxo-2H-chromen-3-yl)-5-phenyl-cyclopenta[b]pyra- no-pyrimidine-4,6-5H-dione from 4a and coumarin-3-carboxylic The newly synthesized compounds were screened for their in vit- acid. ro antibacterial activity against Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae bacterial strains by the serial plate dilution method. Serial dilutions of the drug in Mul- time of 30 s at room temperature. Specimens for XRD were ler Hinton broth were taken in tubes and their pH was adjusted prepared by compaction into a glass-backed aluminum sample to 5.0 using phosphate buffer. A standardized suspension of the holder. Data were collected over a 2h range from 4 to 75 . The test bacterium was inoculated and incubated for 16–18 h at fresh catalyst and recovered catalyst were characterized by 37 C. The MIC is the lowest concentration of the drug for XRD and their pattern is presented in Fig. 2. As it is shown which no growth is detected. The results are summarized in Synthesis of cyclopenta[b]pyrano pyrimidinone derivatives 7
O H O SO 3H SO 3 O HO CN HO + O O O O O NH2 a 4a SBPDSA = SO3H
Heat -H O 2 SO3H O O NH SO3 SO3H CN O O Heat O N O N b H c H O O O O
SO3
O NH O O O Heat NH O SO2 O SO2 O N H O N d e H O O O O
SO3
O O O O SO3H SO3 NH NH O N O N H f 6a O O O O
Scheme 3 A possible mechanism for the formation of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-aryl-cyclopenta[b] pyrano-pyrimidine- 4,6-5H-dione derivatives.
Figure 2 XRD pattern of fresh and recovered SBPDSA.
Table 4. The MIC values were evaluated at concentration range, found to have antibacterial activity against E. coli, P. aerugi- 12.5–25 lg/mL. Upon exploration of the antibacterial activity nosa and K. pneumoniae, and Staphylococcus aureus when com- data (Table 4), it has been observed that all compounds were pared with the employed standard drug. 8 P.N. Sudhan, S. Sheik Mansoor
Table 4 In vitro antibacterial and antifungal activities of compounds 6a–j. Compounds Minimum inhibitory concentration (MIC) in lg/mL Antibacterial activity Antifungal activity E. coli P. aeruginosa K. pneumonia A. flavus R. schipperae A. niger 6a 150 100 150 150 150 150 6b 100 50 75 125 75 75 6c 25 25 25 50 25 50 6d 50 50 50 50 50 50 6e 75 50 75 100 75 100 6f 75 75 75 100 100 100 6g 150 150 150 150 150 150 6h 150 100 150 150 150 150 6i 75 75 75 100 75 100 6j 75 50 75 100 75 100 Ciprofloxacin 25 12.5 25 – – – Amphotericin-B – – – 50 25 50
3.3. Antifungal activity 3.5. Acute toxicity
Newly prepared compounds were also screened for their anti- The median lethal doses (LD50) of the synthesized compounds fungal activity against Aspergillus flavus, Rhizopus schipperae 6a–j were determined in mice (Sztaricskai et al., 1999). Groups and Aspergillus niger in DMSO by the serial plate dilution of male adult mice, each of six animals, were injected i.p. with method. Sabourauds agar media were prepared by dissolving graded doses of each of the test compounds. The percentage of peptone (1 g), D-glucose (4 g) and agar (2 g) in distilled water mortality in each group of animals was determined 24 h, after (100 mL) and adjusting the pH to 5.7. Normal saline was used injection. Computation of LD50 was processed by a graphical to make a suspension of sore of fungal strains for lawning. method. The LD50 values for 6a–j were 20–30 times higher Activity of each compound was compared with Ampho- than its MIC. tericin-B as standard. The results are summarized in Table 4. The MIC values were evaluated at concentration range, 4. Conclusions 25–50 lg/mL. The results given in Table 4 show that all com- pounds exhibited antifungal activity with MIC against A. flavus, We have developed a green and simple protocol for the synthe- R. schipperae and A. niger compared with Amphotericin-B as sis of 7,8-dihydro-2-(2-oxo-2H-chromen-3-yl)-5-phenyl-cy- standard drug. clopenta[b]pyrano-pyrimidine-4,6-5H-dione derivatives via the condensation of 2-amino-4-phenyl-5-oxo-4,5,6,7-tetrahy- 3.4. Influence of aromatic substituents drocyclopenta[b]pyran-3-carbonitrile derivatives and coumar- in-3-carboxylic acid using SBPDSA as an efficient novel The results suggest that the antibacterial and antifungal activ- catalyst. This procedure is a promising strategy and has advan- ities are markedly influenced by the aromatic substituents. tages such as easy workup and eco-friendliness. It is expected Compound 6a without any substituent in the aryl moiety exhi- that the present methodology will find application in organic bits antibacterial activity in vitro at 150, 100 and 150 lg/ml synthesis. All the synthesized compounds were screened for against E. coli, P. aeruginosa and K. pneumonia respectively their in vitro antimicrobial activity compared to the standard and also exhibits antifungal activity in vitro at 150, 150 and drug Ciprofloxacin and Amphotericin-B for antibacterial and 150 lg/ml against A. flavus, R. schipperae and A. niger, respec- antifungal activity respectively. tively. Compounds 6c, 6d and 6e with electron-withdrawing substituents in the aromatic ring show greater antibacterial Acknowledgments activity than the other compounds against all the tested organ- isms. Also, compounds 6c and 6d show greater antifungal activ- The authors are thankful to the Management of C. Abdul ity than all the other compounds against all the tested Hakeem College, Melvisharam – 632 509, Tamil Nadu, India organisms. The aromatic substituents in 6c and 6e have positive for the facilities and support. values for the Hammett substituent constant rp [NO2 (+0.78) and Cl (+0.23)] and the aromatic substituent in 6d also has References positive value for the Hammett substituent constant rm [Br (+0.40)]. The aromatic substituents in 6b and 6h have negative Asadipour, A., Alipour, M., Jafari, M., Khoobi, M., Emami, S., values for the Hammett substituent constant r [CH (À0.17) p 3 Nadri, H., Sakhteman, A., Moradi, A., Sheibani, V., Moghadam, and N(CH ) ( 0.205)] and the aromatic substituent in 6i also 3 2 À F.H., Shafiee, A., Foroumadi, A., 2013. Novel coumarin-3- has negative value for the Hammett substituent constant rm carboxamides bearing N-benzylpiperidine moiety as potent acetyl- [CH3 (À0.069)]. The Hammett substituent constant r for the cholinesterase inhibitors. Eur. J. Med. Chem. 70, 623–630. aromatic substituents in 6f and 6g is rm OH (+0.12) and rp Augustine, J.K., Bombrun, A., Ramappa, B., Boodappa, C., 2012. An OH (À0.37), respectively. Hence, 6f is more active than 6g. efficient one-pot synthesis of coumarins mediated by propylphos- Synthesis of cyclopenta[b]pyrano pyrimidinone derivatives 9
phonic anhydride (T3P) via the Perkin condensation. Tetrahedron cyclic compounds using DMAP as a catalyst. Tetrahedron Lett. 52, Lett. 53, 4422–4425. 5327–5332. Avin, B.R.V., Thirusangu, P., Ranganatha, V.L., Firdouse, A., Khan, A.T., Das, D.K., Islam, K., Das, P., 2012. A simple and Prabhakar, B.T., Khanum, S.A., 2014. Synthesis and tumor expedient synthesis of functionalized pyrido[2,3-c]coumarin deriva- inhibitory activity of novel coumarin analogs targeting angio- tives using molecular iodine catalyzed three-component reaction. genesis and apoptosis. Eur. J. Med. Chem. 75, 211–221. Tetrahedron Lett. 53, 6418–6422. Banothu, J., Bavanthula, R., 2012. Brønsted acidic ionic liquid Khoobi, M., Ramazani, A., Foroumadi, A.R., Hamadi, H., Hojjati, catalyzed highly efficient synthesis of chromeno pyrimidinone Z., Shafiee, A., 2011. Efficient microwave-assisted synthesis of 3- derivatives and their antimicrobial activity. Chin. Chem. Lett. 23, benzothiazolo and 3-benzothiazolino coumarin derivatives cat- 1015–1018. alyzed by heteropoly acids. J. Iran. Chem. Soc. 8, 1036–1042. Dimroth, O., 1909. Ueber intramolekulare Umlagerungen. Khurana, J.M., Kumar, S., 2009. Tetrabutylammonium bromide Umlagerungen in der Reihe des 1, 2, 3-triazols. Justus Liebigs (TBAB): a neutral and efficient catalyst for the synthesis of Ann. Chem. 364, 183–226. biscoumarin and 3,4-dihydropyrano[c]chromene derivatives in Foucourt, A., Dubouilh-Benard, C., Chosson, E., Corbiere, C., water and solvent-free conditions. Tetrahedron Lett. 50, 4125– Buquet, C., Iannelli, M., Leblond, B., Marsais, F., Besson, T., 4127. 2010. Microwave-accelerated Dimroth rearrangement for the Rahi, T., Baghernejad, M., Niknam, K., 2012. Silica-bonded N-propyl synthesis of 4-anilino-6-nitroquinazolines. Application to an effi- diethylenetriamine sulfamic acid as a recyclable solid acid catalyst cient synthesis of a microtubule destabilizing agent. Tetrahedron for the synthesis of a-aminonitriles. Chin. J. Catal. 33, 1095–1100. 66, 4495–4502. Rajguru, D., Keshwal, B.S., Jain, S., Bhagwat, V.W., 2013. Alum
Ghashang, M., Mansoor, S.S., Aswin, K., 2013. Synthesis and in vitro [KAl(SO4)2Æ12H2O]: a green and efficient catalyst for synthesis of microbiological evaluation of novel series of 8-hydroxy-2-(2-oxo- pyrano[4,3-b]pyrans in water under conventional and microwave 2H-chromen-3-yl)-5-phenyl-3H-chromeno[2,3-d]pyrimidin-4(5H)- conditions. Monatsh. Chem. 144, 1411–1416. one derivatives catalyzed by reusable silica-bonded N-propylpiper- Renuka, N., Kumar, K.A., 2013. Synthesis and biological evaluation azine sulfamic acid. Res. Chem. Intermed. http://dx.doi.org/ of novel formyl-pyrazoles bearing coumarin moiety as potent 10.1007/s11164-013-1419-2. antimicrobial and antioxidant agents. Bioorg. Med. Chem. Lett. Ghashang, M., Aswin, K., Mansoor, S.S., 2014a. An eco-friendly 23, 6406–6409. catalytic route for one-pot synthesis of 2-amino-6-(2-oxo-2H- Sashidhara, K.V., Modukuri, R.K., Choudhary, D., Rao, K.B., chromen-3-yl)-4-arylnicotinonitrile derivatives by silica-supported Kumar, M., Khedgikar, V., Trivedi, R., 2013. Synthesis and
perchloric acid (HClO4–SiO2) under solvent-free conditions. Res. evaluation of new coumarine pyridine hybrids with promising anti- Chem. Intermed. 40, 1135–1145. osteoporotic activities. Eur. J. Med. Chem. 70, 802–810. Ghashang, M., Mansoor, S.S., Aswin, K., 2014b. Pentafluoropheny- Sefat, M.N., Deris, A., Niknam, K., 2011. Preparation of silica- lammonium triflate (PFPAT) catalyzed facile construction of bonded propyl-diethylene-triamine-N-sulfamic acid as a recyclable substituted chromeno[2,3-d]pyrimidinone derivatives and their catalyst for chemoselective synthesis of 1,1-diacetates. Chin. J. antimicrobial activity. J. Adv. Res. 5, 209–218. Chem. 29, 2361–2367. Ghosh, P.P., Das, A.R., 2012. Nano crystalline ZnO: a competent and Sztaricskai, F., Takacs, E.I., Pusztai, F., Szabo, G., Csipo, I., 1999. reusable catalyst for one pot synthesis of novel benzylamino Antiulcer effect of 5-amino salicylic acid. Arch. Pharm. Med. coumarin derivatives in aqueous media. Tetrahedron Lett. 53, Chem. 332, 321–326. 3140–3143. Witaicenis, A., Seito, L.N., da Silveira Chagas, A., de Almeida Jr., Jashari, A., Imeri, F., Ballazhi, L., Shabani, A., Mikhova, B., Drager, L.D., Luchini, A.C., Rodrigues-Orsi, P., Cestari, S.H., Di Stasi, G., Popovski, E., Huwiler, A., 2014. Synthesis and cellular L.C., 2014. Antioxidant and intestinal anti-inflammatory effects of characterization of novel isoxazolo- and thiazolo hydrazinylidene- plant-derived coumarin derivatives. Phytomedicine 21, 240–246. chroman-2,4-diones on cancer and non-cancer cell growth and Zhang, W., Li, Z., Zhou, M., Wu, F., Hou, X., Luo, H., Liu, H., Han, death. Bioorg. Med. Chem. 22, 2655–2661. X., Yan, G., Ding, Z., Li, R., 2014. Synthesis and biological Kawate, T., Iwase, N., Shimizu, M., Stanley, S.A., Wellington, S., evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential Kazyanskaya, E., Hung, D.T., 2013. Synthesis and structure– antitumor agents. Bioorg. Med. Chem. Lett. 24, 799–807. activity relationships of phenyl-substituted coumarins with anti- Zhao, L., Yao, Y., Li, S., Lv, M., Chen, H., Li, X., 2014. Cytotoxicity tubercular activity that target FadD32. Bioorg. Med. Chem. Lett. and DNA binding property of triphenylethylene-coumarin 23, 6052–6059. hybrids with two amino side chains. Bioorg. Med. Chem. Lett. Khan, A.T., Lal, M., Ali, S., Khan, M.M., 2011. One-pot three- 24, 900–904. component reaction for the synthesis of pyran annulated hetero- Journal of the Association of Arab Universities for Basic and Applied Sciences (2016) 21,10–16
University of Bahrain Journal of the Association of Arab Universities for Basic and Applied Sciences www.elsevier.com/locate/jaaubas www.sciencedirect.com
ORIGINAL ARTICLE Synthesis, characterization and in vitro drug release of cisplatin loaded Cassava starch acetate–PEG/ gelatin nanocomposites
V. Raj *, G. Prabha
Advanced Materials Research Laboratory, Department of Chemistry, Periyar University, Salem 11, Tamil Nadu, India
Received 27 April 2015; revised 6 August 2015; accepted 23 August 2015 Available online 19 November 2015
KEYWORDS Abstract The aim of the present study is to examine the feasibility of Cassava starch acetate Cassava starch acetate; (CSA)–polyethylene glycol (PEG)–gelatin (G) nanocomposites as controlled drug delivery systems. Drug delivery; It is one of the novel drug vehicles which can be used for the controlled release of an anticancer Polyethylene glycol (PEG); drug. Simple nano precipitation method was used to prepare the carriers CSA–PEG–G nanocom- Gelatin; posites and they were used for entrapping cisplatin (CDDP). Through FT-IR spectroscopy, the Cisplatin; linking among various components of the system was proved and with the help of scanning electron Nanocomposites microscope and transmission electron microscopy (TEM), the surface morphology was investigated. The particle sizes of the CSA–CDDP, CSA–CDDP–PEG and CSA–CDDP–PEG–G polymer com- posites were between 140 and 350 nm, as determined by a Zetasizer. Drug encapsulation efficiency, drug loading capacity and in vitro release of CDDP were evaluated respectively. The findings revealed that the cross linked CSA–PEG–G nanocomposites can be a potential polymeric carrier for controlled delivery of CDDP. Ó 2015 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction One of the efficacious methods, applied in this study to improve the properties of starch, is the chemical modification Starch, a biodegradable polymer is a promising carrier for of starch which includes esterification. Over the past two dec- drug delivery. It has been used in various fields like biomedical, ades extensive studies have been conducted on starch ester agriculture and food etc. However, native starch cannot fit into called as acetylated starch (Wang and Wang, 2002). Chemi- some parental controlled drug delivery systems, as many drugs cally transformed starch acetates are less hydrophilic than are released quickly from such unmodified starch-based sys- most of the other modified starches, due to the hydrophobic tems (Michailova et al., 2001); due to considerable swelling nature of the acetoxy substituent (OCOCH3). In the drug and quick enzymatic degradation of native starch in biological delivery applications, starch acetate has been extensively used systems. (Korhonen et al., 2004; Nutan et al., 2005, 2007; Pajander et al., 2008; Pohja et al., 2004; Pu et al., 2011; Tuovinen * Corresponding author. Tel.: +91 9790694972, +91 9789703632. et al., 2004a,b; van Veen et al., 2005; Xu et al., 2009) and tissue E-mail address: [email protected] (V. Raj). engineered scaffold has also been investigated (Guan and Peer review under responsibility of University of Bahrain. Hanna, 2004; Reddy and Yang, 2009). http://dx.doi.org/10.1016/j.jaubas.2015.08.001 1815-3852 Ó 2015 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Drug release of cisplatin loaded cassava starch acetate 11
In cancer chemotherapy, platinum compounds play an The reaction was carried out at 120 °C for a period of 3 h. important role. One of the most common anticancer agents The final product was precipitated with ethanol, filtered and is Cisplatin (CDDP), the first generation of platinum based dried in vacuum oven. Lastly, the modified starch was milled chemotherapy drug. It is used in the treatment of solid tumors and sifted in a sieve (#50 mesh) to obtain a homogeneous par- including gastrointestinal, head and neck, genitourinary and ticle size and stored in desiccators until further study. lung tumors (Kelland, 2007; Boulikas and Vougiouka, 2003). The clinical application of cisplatin for cancer chemother- 2.3. Preparation of CSA–CDDP nanorods apy is still in limited use because of its nonspecific bio- distribution and severe side effects. In an attempt to overcome The CSA nanorods were prepared by a simple nanoprecipita- this shortcoming, various studies have been conducted by tion technique as reported by Chin et al., 2011 with slight mod- many groups. They are magnetically mediated controlled ification. CSA (10 mg) was dissolved in 8:10 wt% of NaOH/ delivery systems (Likhitkar and Bajpai, 2012), click chemistry urea (NU) solution mixtures; this solution mixture was used (Huynh et al., 2011), SiO2/polymer for the controlled release of as a solvent system for the dissolution of acetylated cassava cisplatin (Czarnobaj and Lukasiak, 2007), platinum-tethered starch. Cisplatin was dissolved in CSA solution and prepared gold nanoparticle (Brown et al., 2010). Chemotherapy with cis- at various concentrations i.e., 10%, 20%, 30%, 40% and platin is connected with some serious side effects, such as: 50%, using 4, 8, 12, 16 and 20 mg of drug, respectively. An ali- vomiting, nephrotoxicity, ototoxicity, neuropathy, anemia quot of CSA solution (10 mg/mL) containing the various con- and nausea (Uchino et al., 2005). Owing to these side effects centrations of the drugs was added drop-wise into a 10 ml of other methods of administering cisplatin are required. In the absolute ethanol solution, which was constantly stirred using present study, CSA/PEG/G has been chosen as the raw mate- a magnetic stirrer at a constant stirring rate (1500 rpm). The rial to prepare the drug carrier. CSA nanorods were made immediately. This dispersion of The key objective of the current study is to encapsulate the anti- nanorods was vacuum evaporated to remove the organic sol- cancer drug cisplatin (CDDP) into Cassava starch acetate/poly- vent fully. Finally the resultant mixture was centrifuged at ethylene glycol/gelatin (CSA/PEG/G) nanocomposites through 13,000 rpm and the supernatant was removed to obtain the the interaction between cisplatin (CDDP) and CSA/PEG/G CSA-cisplatin nanorods and freeze-dried at 40 °C for 20 h. nanocomposites. Gelatin is a naturally occurring biodegradable macromolecule with well-documented biocompatible properties 2.4. Preparation of the CSA–CDDP–PEG and CSA–CDDP– over other synthetic polymers that make it an appropriate material PEG–G nanocomposites to be used as a nanoparticulate carrier (Lai et al., 2006). To develop the microspheres, nanoparticles and polymers, Polyethy- The various percentage of encapsulated CSA–CDDP in the lene glycol (PEG), a suitable graft-forming polymer, has been PEG and G solution were prepared by a method described extensively employed in pharmaceutical and biomedical fields in our previous report (Rajan et al., 2013) as follows. First, (Jeong et al., 2008). The viability of CDDP-loaded polymeric 10% of PEG solution was prepared in water. Then, the solu- nanocomposites as a drug delivery system was verified by tion was gradually added to a correct portion of the CSA– evaluating its in vitro studies and instrumental characteristics. CDDP nanorods under constant magnetic stirring at room temperature for 1 h. The resulting encapsulated nanocompos- 2. Materials and methods ites (CSA–CDDP–PEG) were collected by centrifugation at 1500 rpm and freeze-dried at 30 °C for 20 h. Later gelatin 2.1. Materials (20 mg) was dissolved in water in a similar manner and grad- ually added to CSA–CDDP–PEG nanocomposites under con- Native Cassava starch powder was obtained from Sago Serve stant magnetic stirring at room temperature for 1 h. Finally the Industries (Salem, India). Acetic acid (P99%) and acetic resulting encapsulated nanocomposites (CSA–CDDP–PEG– anhydride (P98%) were of analytical grade procured from G) were collected by centrifugation at 1500 rpm and freeze- Sigma–Aldrich (St. Louis, USA). PEG 10000, gelatin Type- dried at 30 °C for 20 h. B, phosphate-buffered saline (PBS) were prepared in deionized 3 water using NaCl (0.14 M), KCl (2.68 10 M), Na2HPO4 2.5. Particle size analysis 3 (0.01 M), KH2PO4 (1.76 10 M). Sodium hydroxide (NaOH) and absolute ethanol were purchased from Merck Drug loaded polymeric nanocomposites were characterized for (Mumbai, India Ltd). Cisplatin was obtained from Dabur the particle size, size distribution and zeta potential using Zeta- Pharma Ltd. (New Delhi, India). All chemicals were used with- sizer (Malvern Instruments, UK). out additional purification. 2.6. Scanning electron microscopy (SEM) and Fourier 2.2. Preparation of cassava starch acetate transform infrared spectroscopy (FT-IR) analysis
Native cassava starch was permitted to react with acetic anhy- Morphological characteristics of the freshly prepared (CSA– dride (1:4 ratio) with pyridine as a catalyst as previously CDDP, CSA–CDDP–PEG, and CSA–CDDP–PEG–G) described (Singh and Nath, 2012) with few modifications. nanocomposites were viewed using scanning electron micro- Before acetylation, cassava starch was dried in an oven for scopy (SEM-Hitachi-S-2700), FT-IR spectrum was taken to 20 h at 45–60 °C. Dried starch (25 g) was mixed with acetic study the interaction between polymers and drug using Perkin anhydride (100 g) through the medium of pyridine (200 g). Elmer spectrum RXI. KBr pellets were concisely prepared by 12 V. Raj, G. Prabha mixing 1 mg of the sample with 200 mg of KBr. Fourier Trans- nanocomposites increases slightly with an increase in the % form Infrared spectroscopy (400–4000 cm 1) was performed of CDDP encapsulation. The size of the nanocomposites, with a resolution of 2 cm 1. which is increased once again, is due to the coordination of PEG and G with CSA–CDDP. The 10% of CDDP loaded 2.7. TEM analysis CSA, CSA–PEG, CSA–PEG–G nanocomposites displayed a mean particle size value of 143,239 and 311 nm respectively The shape and morphology of the Cisplatin loaded CSA, as shown in (Table 1). CSA–PEG and CSA–PEG–G nanocomposites were investi- Zeta potential tells about the charge on the surface of the gated by transmission electron microscopy (TEM, Hitachi polymeric nanocomposites and plays an important role in the H-600-II) operated at 200 kV. stability of the particles in suspension through the electrostatic repulsion between the particles (Wilson et al., 2011). The repul- 2.8. Determination of encapsulation efficiency (EE) and loading sion among the polymeric nanocomposites with the same type of capacity (LC) surface charge provides extra stability (Zhao et al., 2010). The 10% of CDDP loaded CSA, CSA–PEG, CSA–PEG–G nanocomposites exhibited a mean zeta potential value of The suspensions of the drug-loaded polymeric nanocomposites 24.6 mV, 15.3 mV and 10.0 mV, respectively (Table 1) that were centrifuged at 17,000 rpm for 40 min and the EE and LC lies in the stable range indicating that the prepared nanocom- of drug loaded polymeric nanocomposites were determined by posite systems were stable. The negative values obtained for quantifying the absorption of the clear supernatant using a the zeta potential indicate that the polymeric nanocomposites UV-spectrophotometer (Elico SL 159, India). The correspond- surface is negatively charged. This negative charge may be due ing calibration curves were made by testing the supernatant of to the availability of the free acetyl groups on the polymer. blank polymeric nanocomposites. Tests were performed in Negative zeta potential values are detected in all cases, suggest- triplicate for each sample. The absorbance value of CDDP ing that CSA chains are primarily located on the surface of the was measured using a UV–vis spectrophotometer at the wave- particles. All the zeta potential experiments were done in the length of 290 nm. The percentage of encapsulation efficiency aqueous medium after centrifuging the nanocomposites at and loading capacity of CDDP in the CSA, CSA–PEG and 15,000 rpm for 30 min and dispersed in millipore water. CSA–PEG–G nanocomposites are determined by the follow- ing equations (Eqs. (1) and (2)), respectively, as reported ear- 3.1.2. Fourier transmission infrared spectroscopy (FT-IR) lier (Papadimitriou et al., 2008), which are as follows: analysis = % EE ¼ðWt WfÞ Wt 100 ð1Þ The FT-IR spectra of native and acetylated cassava starch are given in Fig. 1. In the spectrum of native starch, there are some = % LC ¼ðWt WfÞ Wn 100 ð2Þ discernible absorbencies at 1157, 1016 cm 1, which are attribu- where Wt is the total amount of CDDP; Wf is the amount of ted to C–O bond stretching (Goheen and Wool, 1991). Other free CDDP in the supernatant after centrifugation; and Wn characteristic absorption bands at 928, 859, 765, and is the weight of polymeric nanocomposites after freeze- 576 cm 1 are due to the whole anhydroglucose ring stretching drying. All measurements were made in triplicate and the aver- vibrations (Cherif Ibrahima Khalil et al., 2011). The very broad age value was reported. band between 3000–3600 cm 1 and 2931 cm 1 corresponds to OH and CH stretching respectively (Kacurakova and Wilson, 2.9. Evaluation of in vitro drug release 2001) while the peaks at 1648 cm 1 and 1420 cm 1 correspond to d (OH) and d (CH) bendings (Mano et al., 2003). Compared to native starch, starch acetates had a strong absorption band The in vitro drug release tests were carried out on all formula- 1 tions (2%, 4%, 6%, 8%, and 10% drug loaded samples). at 1730 cm that is attributed to the stretching vibration of ‚ Nearly 0.1 mg of each sample was suspended in a definite vol- the ester carbonyl C O and indicated the acetylation of starch. ume (10 ml) of phosphate buffer saline (PBS) at various pH at FT-IR spectra of various CSA–CDDP, CS–CDDP–PEG, 37 °C. The resulting suspension was placed in an incubated and CSA–CDDP–PEG–G nanopolymer composites are shown in Fig. 2a. The CSA spectra exhibited band at shaker at 120 rpm for a definite time period (1 h) and five- 1 milliliter aliquots were taken out of the dissolution medium 1730 cm relative to the stretching of the ester carbonyl (C‚O) group of acetylated cassava starch. The addition of at appropriate time intervals (30 min), replaced by same vol- 1 ume of fresh PBS buffer, to keep the volume of the release PEG and gelatin led to bands at 1666 cm relative to the medium constant. The amount of drug released was observed stretching of the ester carbonyl group (Lin et al., 2007). Thus by UV spectrophotometer (Systronics, India) at 290 nm. the shift in the peak toward a lower field than the actual field indicates the physical mixture of CSA, PEG, and gelatin. The amino peak of gelatin in the polymer composite was shifted 3. Results and discussion from 1542 to 1547 cm–1. The amide I absorption was primarily due to the stretching vibration of the C–O bond and the amide 3.1. Characterization of polymeric nanocomposites II band was due to the coupling of the bending of the N–H bond and the stretching of the C–N bond. This result proves 3.1.1. Preparation and characterization of CDDP loaded that there is an interaction between the CSA and the amino polymeric nanocomposites groups of gelatin. Table 1 represents the particle size and zeta potentials of the Furthermore, strong characteristic peaks of CDDP are not CDDP loaded polymeric nanocomposites. The size of the sensed at the same position in the drug-loaded nanocompos- Drug release of cisplatin loaded cassava starch acetate 13
Table 1 The particle size and zeta potential values of CSA–CDDP, CSA–CDDP–PEG and CSA–CDDP–PEG–G. % of CDDP concentration Particle size (nm) mean ± SDa ZP (mV) mean SDa CSA–CDDP CSA–CDDP–PEG CSA–CDDP–PEG–G CSA–CDDP CSA–CDDP–PEG CSA–CDDP–PEG–G 10 143.2 ± 12.5 239.0 ± 11.8 311.7 ± 05.0 24.6 ± 1.1 15.3 ± 1.4 10.0 ± 2.0 20 154.4 ± 12.7 245.5 ± 05.8 325.4 ± 10.1 22.3 ± 1.5 13.5 ± 1.7 08.1 ± 1.1 30 168.0 ± 08.6 261.3 ± 15.3 333.6 ± 12.4 20.1 ± 2.2 13.0 ± 1.5 07.3 ± 3.2 40 185.5 ± 11.3 270.1 ± 10.1 345.3 ± 10.3 18.8 ± 1.5 11.2 ± 2.3 06.1 ± 1.4 50 193.2 ± 12.5 274.8 ± 13.6 350.1 ± 07.2 19.5 ± 1.8 10.4 ± 1.4 05.5 ± 1.5 CDDP: Cisplatin; CSA: Cassava starch acetate; PEG: polyethylene glycol; G: gelatin; SD: standard deviation for three determinations. a n = 3. The experiments were repeated twice.
1.0 (a) a 100 0.8
80 0.6
0.4 60
0.2 40
0.0 Transmittance (%) 20 CSA-CDDP 1.0 b CSA-CDDP-PEG 0 CSA-CDDP-PEG-G 0.8 1000 2000 3000 4000 Transmittance (%) 0.6 Wavenumber cm-1
0.4 (b) 100
0.2 80 0.0 0 1000 2000 3000 4000 5000 60 Wavenumber cm-1
Figure 1 FTIR spectra of (a) acetylation of cassava starch, (b) 40 native cassava starch. Transmittance (%)
20 ites, identifying an interaction between the drug and the poly- 10% CSA-CDDP-PEG-G mer composites. Also, the peaks were shifted toward a lower 50% CSA-CDDP-PEG-G field than the actual field, and this shift was due to the hydro- 0 gen bond in the encapsulated polymer composites. Fig. 2b 1000 2000 3000 4000 indicates the FT-IR spectra of the 10 and 50% of CDDP Wavenumber cm-1 coated CSA–CDDP–PEG–G polymeric nanoparticles. The spectra of the coated polymeric nanoparticles displayed the Figure 2 FTIR spectra of (a) and (b) cisplatin loaded same peaks that vary only in intensity. nanocomposites.
3.1.3. Scanning electron microscopy (SEM) of drug loaded polymeric nanocomposites can be seen in the SEM of the secondary mixed-film due to The SEM images of CSA–CDDP, CSA–CDDP–PEG and C the physical mixture of PEG and G to the CSA. The mixture SA–CDDP–PEG–G nanocomposites are shown in Fig. 3. of CSA with CDDP exhibited certain immiscibility. A clear In addition, the combination of CDDP with nanocompos- uniform surface of the G cross-linked polymer composite is ites produced a smooth surface and compact structure shown in Fig. 3c. The coating lying of CDDP with CSA Fig. 3b and c. Particle accumulation and a smooth surface exposed a rough surface. The coating lying of PEG with gela- 14 V. Raj, G. Prabha
Figure 3 SEM images of cisplatin loaded (a) CSA, (b) CSA–PEG, (c) CSA–PEG–G nanocomposites.
Figure 4 TEM images of cisplatin loaded (a) CSA, (b) CSA–PEG, (c) CSA–PEG–G nanocomposites.
Table 2 Encapsulation efficiency (EE) and loading capacity (LC) of CSA–CDDP, CSA–CDDP–PEG and CSA–CDDP–PEG–G nanocomposites. % of CDDP concentration CSA–CDDP nanocomposites CSA–CDDP–PEG nanocomposites CSA–CDDP–PEG–G nanocomposites % of EE % of LC % of EE % of LC % of EE % of LC 10 23.9 05.3 45.3 10.1 66.9 14.9 20 62.3 22.7 75.5 27.4 84.0 30.5 30 75.4 34.8 85.5 39.4 90.4 41.7 40 82.0 43.8 89.4 47.7 93.6 49.2 50 85.9 50.6 91.6 53.9 94.1 57.0 tin revealed a smoother surface and rod shaped structure, dis- initial concentration of CDDP is same, which might be accred- playing an enhanced encapsulation efficiency and a more con- ited to the fact that CSA–PEG–G nanocomposites have more sistent structure. attraction than CSA and CSA–PEG nanocomposites with CDDP. The drug encapsulation efficiency (EE) and drug load- 3.1.4. Transmission electron microscopy (TEM) analysis ing capacity (LC) of high percentage of (50%) CDDP loaded The surface morphology of the Cisplatin loaded CSA, CS– CSA, CSA–PEG & CSA–PEG–G nanocomposites were found PEG, and CSA–PEG–G nanocomposites was observed by to be 85.9%, 91.6% & 94.1% and 50.6%, 53.9%, &57.0%, TEM as shown in Fig. 4. Fig. 4a–c illustrates that the CSA– respectively (Table 2). CDDP, CSA–CDDP–PEG, CSA–CDDP–PEG–G nanocom- posites have spherical morphology and are homogeneously 3.3. In vitro drug release studies distributed with an average diameter of 50–100 nm. In vitro drug release studies were done via direct dispersion 3.2. Encapsulation efficiency (EE) and loading capacity (LC) method as explained in the literature (Bisht et al., 2007; Anitha et al., 2011) at pH 3.4 & 7.4 and release pattern is The initial concentration of CDDP played a significant role in shown in Fig. 5. The percentage release of CDDP from CSA deciding the drug encapsulation efficiency (EE) and drug load- was slightly greater when compared to that of CSA–PEG ing capacity (LC) of the CSA, CSA–PEG and CSA–PEG–G and CSA–PEG–G combined nanocomposites. For the CSA– nanocomposites as shown in Table 2. When the concentration CDDP, CSA–CDDP–PEG and CSA–CDDP–PEG–G coated of CDDP is increased, the EE & LC of CSA, CSA–PEG and nanocomposites, the percentage of CDDP released from the CSA–PEG–G nanocomposites is also increased. The EE & nanocomposites was initially much larger and then very slow LC of CSA–PEG–G nanocomposites is somewhat more than after some hours, similar to that reported by other authors that of the CSA and CSA–PEG nanocomposites when at the (Li et al., 2008; Chen et al., 2009, 2011; Yang et al., 2008; Drug release of cisplatin loaded cassava starch acetate 15
Figure 5 In vitro analysis of cisplatin encapsulated nanocomposites.
Zhang et al., 2009). Fig. 5 shows the release profile at both the sary instrumental facilities and the dedicated support of C. pH for the same drug loading, as the pH value of the releasing Vijayabhaskar. buffer increased, the releasing rate of CDDP increased. From Fig. 5, we also found that the release rate of the CDDP which References was loaded in the CSA, CSA–PEG and CSA–PEG–G loaded nanocomposites was much lower than the free CDDP. The Anitha, A., Maya, S., Deepa, N., Chennazhi, K.P., Nair, S.V., results indicated that the release of CDDP from CSA, CSA– Tamura, H., 2011. Efficient water-soluble biodegradable polymeric PEG and CSA–PEG–G nanocomposites is pH dependant, nanocarrier for the delivery of curcumin to cancer cells. Carbohydr. the CDDP released faster in acidic environment than at basic Polym. 83, 452–461. environment as a consequence of binding between drug and Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, M., the carboxyl group in cassava starch acetate nanocomposites 2007. Polymeric nanoparticle-encapsulated curcumin (‘‘nanocur- cumin”): a novel strategy for human cancer therapy. J. which could be recovered by the attacking of H+ or Cl .At Nanobiotechnol. 5, 3. http://dx.doi.org/10.1186/1477-3155r-r5-3. body environment, the Cl concentration is very high (95– Boulikas, T., Vougiouka, M., 2003. Cisplatin and platinum drugs at 105 mM) and relatively stable in body circulation, more acidic the molecular level. Oncol. Rep. 10, 1663–1683. + environment means more H which can speed up the release Brown, S.D., Nativo, P., Smith, J.A., Stirling, D., Edwards, P.R., of CDDP from the coated polymeric nanocomposites. Venugopal, B., Flint, D.J., Plumb, J.A., Graham, D., Wheate, N.J., 2010. Gold nanoparticles for the improved anticancer drug delivery 4. Conclusions of the active component of oxaliplatin. J. Am. Chem. Soc. 132 (13), 4678. Chen, H.L., Yang, W.Z., Chen, H., Liu, L.R., Gao, F.P., Yang, X.D., In this study, a novel formulation of CDDP loaded CSA, 2009. Surface modification of mitoxantrone-loaded PLGA nano- CSA–PEG, CSA–PEG–G nanocomposites was successfully spheres with chitosan. Colloids Surf. B 73, 212–218. developed and characterized. Size and shape of the prepared Chen, M., Liu, Y., Yang, W., Li, X., Liu, L., Zhou, Z., 2011. nanocomposites were examined using SEM and TEM. Also, Preparation and characterization of self-assembled nanoparticles of the various suspended groups present in the composites have 6-O-cholesterol-modified chitosan for drug delivery. Carbohydr. been determined through the FT-IR studies. The nanocompos- Polym. 84, 1244–1251. ites showed pH and time dependent drug release as confirmed Cherif Ibrahima Khalil, D., Hai Long, L., Bi Jun, X., John, S., 2011. by the in vitro drug dissolution profiles. Drug penetration and Effects of acetic acid/acetic anhydride ratios on the properties of corn starch acetates. Food Chem. 26, 1662–1669. in vitro tests suggest that further study is required to develop Chin, S.F., Pang, S.C., Tay, S.H., 2011. Size controlled synthesis of an in vivo drug delivery system. These results suggest that starch nanoparticles by a simple nanoprecipitation method. Car- the CDDP coated CSA, CSA–PEG and CSA–PEG–G bohydr. Polym. 86, 1817–1819. nanocomposites might be used as great potential carriers for Czarnobaj, K., Lukasiak, J., 2007. In vitro release of cisplatin from controlled drug delivery system. sol–gel processed organically modified silica xerogels. J. Mater. Sci. – Mater. Med. 18 (10), 2041. Acknowledgements Goheen, S.M., Wool, R.P., 1991. Degradation of polyethylene starch blends in soil. J. Appl. Polym. Sci. 42, 2691–2701. One of the authors (G. Prabha) would like to acknowledge the Guan, J., Hanna, M.A., 2004. Extruding foams from corn starch acetate and native corn starch. Biomacromolecules 5 (6), 2329– National Centre for Nanoscience and Nanotechnology, 2339. University of Madras, Chennai, India for providing the neces- 16 V. Raj, G. Prabha
Huynh, V.T., Chen, G., Souza, P., Stenzel, M.H., 2011. Thiol-yne and Pohja, S., Suihko, E., Vidgren, M., Paronen, P., Ketolainen, J., 2004. Thiol-ene ‘‘Click” chemistry as a tool for a variety of platinum drug Starch acetate as a tablet matrix for sustained drug release. J. delivery carriers, from statistical copolymers to crosslinked Controlled Release 94 (2–3), 293–302. micelles. Biomacromolecules 12 (5), 1738–1751. Pu, H., Chen, L., Li, X., Xie, F., Yu, L., Li, L., 2011. An oral colon- Jeong, Y., Kim, D.G., Jang, M.K., Nah, J.W., 2008. Preparation and targeting controlled release system based on resistant starch spectroscopic characterization of methoxy poly (ethylene glycol)- acetate: synthetization, characterization, and preparation of film- grafted water-soluble chitosan. Carbohydr. Res. 343, 282–289. coating pellets. J. Agric. Food Chem. 59 (10), 5738–5745. Kacurakova, M., Wilson, R.H., 2001. Developments in mid-infrared Rajan, M., Raj, V., Al-Arfaj, A.A., Murugan, A.M., 2013. Hyalur- FTIR spectroscopy of selected carbohydrates. Carbohydr. Polym. onidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin 44, 291–303. polymer nanocomposites as targeted and controlled drug delivery Kelland, L., 2007. The resurgence of platinum-based cancer vehicles. Int. J. Pharm. 453, 514–522. chemotherapy. Nat. Rev. Cancer 77, 573–584. Reddy, N., Yang, Y., 2009. Preparation and properties of starch Korhonen, O., Kanerva, H., Vidgren, M., Urtti, A., Ketolainen, J., acetate fibers for potential tissue engineering applications. Biotech- 2004. Evaluation of novel starch acetate-diltiazem controlled nol. Bioeng. 103 (5), 1016–1022. release tablets in healthy human volunteers. J. Controlled Release Singh, A.V., Nath, L.K., 2012. Evaluation of acetylated moth bean 95 (3), 515–520. starch as a carrier for controlled drug delivery. Int. J. Biol. Lai, J.Y., Lu, P.L., Chen, K.H., Tabata, Y., Hsiue, G.H., 2006. Effect Macromol. 50 (2), 362–368. of charge and molecular weight on the functionality of gelatin Tuovinen, L., Peltonen, S., Liikola, M., Hotakainen, M., Lahtela- carriers for corneal endothelial cell therapy. Biomacromolecules 7, Kakkonen, M., Poso, A., 2004a. Drug release from starch-acetate 1836–1844. microparticles and films with and without incorporated alpha- Li, X.L., Li, R.T., Qian, X.P., Ding, Y.T., Tu, Y.X., Guo, R., Hu, Y., amylase. Biomaterials 25 (18), 4355–4362. Jiang, X.Q., Guo, W.H., Liu, B.R., 2008. Superior antitumor Tuovinen, L., Ruhanen, E., Kinnarinen, T., Ronkko, S., Pelkonen, J., efficiency of cisplatin-loaded nanoparticles by intratumoral delivery Urtti, A., 2004b. Starch acetate microparticles for drug delivery with decreased tumor metabolism rate. Eur. J. Pharm. Biopharm. into retinal pigment epithelium-in vitro Study. J. Controlled 70, 726–734. Release 98 (3), 407–413. Likhitkar, S., Bajpai, A.K., 2012. Magnetically controlled release of Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., cisplatin from superparamagnetic starch nanoparticles. Carbohydr. Honda, T., 2005. Cisplatin–incorporating polymeric micelles (NC- Polym. 87, 300–308. 6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in Lin, Y., Chen, Q., Luo, H., 2007. Preparation and characterization of rats. Br. J. Cancer 93, 678–687. N-(2-rboxybenzyl) chitosan as a potential pH-sensitive hydrogel for Van Veen, B., Pajander, J., Zuurman, K., Lappalainen, R., Poso, A., drug delivery. Carbohydr. Res. 342, 87–94. Frijlink, H.W., 2005. The effect of powder blend and tablet Mano, J.F., Koniarova, D., Reis, R.L., 2003. Thermal properties of structure on drug release mechanisms of hydrophobic starch thermoplastic starch/synthetic polymer blends with potential acetate matrix tablets. Eur. J. Pharm. Biopharm. 61 (3), 149–157. biomedical applicability. J. Mater. Sci. – Mater. Med. 14, 127–135. Wang, Y.J., Wang, L., 2002. Characterization of acetylated waxy Michailova, V., Titeva, St., Kotsilkova, R., Krusteva, E., Minkov, E., maize starches prepared under catalysis by different alkali and 2001. Influence of hydrogel structure on the processes of water alkaline earth hydroxides. Starch/Sta¨ rke 54, 25–30. penetration and drug release from mixed hydroxypropylmethyl Wilson, B., Samanta, M.K., Muthu, M.S., Vinothapooshan, G., 2011. cellulose/thermally pregelatinized waxy maize starch hydrophilic Design and evaluation of chitosan nanoparticles as novel drug matrices. Int. J. Pharm. 222, 7–17. carrier for the delivery of rivastigmine to treat Alzheimer’s disease. Nutan, M.T., Soliman, M.S., Taha, E.I., Khan, M.A., 2005. Opti- Ther. Delivery 5, 599–609. mization and characterization of controlled release multi-particu- Xu, W., Yang, W., Yang, Y., 2009. Electrospun starch acetate late beads coated with starch acetate. Int. J. Pharm. 294 (1–2), 89– nanofibers: development, properties, and potential application in 101. drug delivery. Biotechnol. Progr. 25 (6), 1788–1795. Nutan, M.T., Vaithiyalingam, S.R., Khan, M.A., 2007. Controlled Yang, X.D., Zhang, Q.Q., Wang, Y.S., Chen, H., Zhang, H.Z., Gao, F. release multiparticulate beads coated with starch acetate: material P., 2008. Self- aggregated nanoparticles from methoxy poly (ethylene characterization, and identification of critical formulation and glycol)-modified chitosan: synthesis; characterization; aggregation process variables. Pharm. Dev. Technol. 12 (3), 307–320. and methotrexate release in vitro. Colloids Surf. B 61, 125–131. Pajander, J., Soikkeli, A.M., Korhonen, O., Forbes, R.T., Ketolainen, Zhang, H.Z., Gao, F.P., Liu, L.R., Li, X.M., Zhou, Z.M., Yang, X.D., J., 2008. Drug release phenomena within a hydrophobic starch 2009. Pullulan acetate nanoparticles prepared by solvent diffusion acetate matrix: FT-IR mapping of tablets after in vitro dissolution method for epirubicin chemotherapy. Colloids Surf. B 71, 19–26. testing. J. Pharm. Sci. 97 (8), 3367–3378. Zhao, D.M., Zhao, X.H., Zu, Y.G., Li, J.L., Zhang, Y., Jiang, R., Papadimitriou, S., Bikiaris, D., Avgoustakis, K., Karavas, E., Geor- Zhang, Z.H., 2010. Preparation, characterization, and in vitro garakis, M., 2008. Chitosan nanoparticles loaded with dorzolamide targeted delivery of folate-decorated paclitaxel-loaded bovine and pramipexole. Carbohydr. Polym. 73, 44–54. serum albumin nanoparticles. Int. J. Nanomed. 5, 669–677. Journal of the Association of Arab Universities for Basic and Applied Sciences (2016) 21,17–23
University of Bahrain Journal of the Association of Arab Universities for Basic and Applied Sciences www.elsevier.com/locate/jaaubas www.sciencedirect.com
ORIGINAL ARTICLE Efficient adsorption of 4-Chloroguiacol from aqueous solution using optimal activated carbon: Equilibrium isotherms and kinetics modeling
Afidah Abdul Rahim a, Zaharaddeen N. Garba a,b,* a School of Chemical Sciences, Universiti Sains Malaysia, 11800 Penang, Malaysia b Department of Chemistry, Ahmadu Bello University, P.M.B. 1044, Zaria, Nigeria
Received 28 July 2015; revised 31 August 2015; accepted 3 September 2015 Available online 29 November 2015
KEYWORDS Abstract The optimal activated carbon produced from Prosopis africana seed hulls (PASH-AC) ° Prosopis africana seed hulls; was obtained using the impregnation ratio of 3.19, activation temperature of 780 C and activation 2 Activated carbon; time of 63 min with surface area of 1095.56 m /g and monolayer adsorption capacity of 498.67 mg/g. Isotherms and kinetics mod- The adsorption data were also modeled using five various forms of the linearized Langmuir eling; equations as well as Freundlich and Temkin adsorption isotherms. In comparing the legitimacy Adsorption; of each isotherm model, chi square (v2) was incorporated with the correlation coefficient (R2)to 4-Chloroguiacol justify the basis for selecting the best adsorption model. Langmuir-2 > Freundlich > Temkin isotherms was the best order that described the equilibrium adsorption data. The results revealed pseudo-second-order to be the most ideal model in describing the kinetics data. Ó 2015 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction Adsorption is one of the most useful and effective among the control technologies (El Haddad et al., 2012, 2013; Recently, one of the most troubling environmental challenges Noreen and Bhatti, 2014; Noreen et al., 2013) for the waste troubling developing countries is water pollution (Galadima water treatment with the most broadly employed adsorbent et al., 2011). Thousands of these water pollutants are chemical being activated carbon due to simplicity in design, lofty contaminants with many of them of organic origin which adsorption capacity and fast adsorption kinetics (Garba include chlorophenols. Guaiacols are among those chemical et al., 2014). Activated carbons (AC) are the most sought after contaminants with pharmacological properties quite analo- adsorbents (Jodeh et al., 2016) due to their versatile surface gous to those of phenol. Chlorinated guaiacols are closely characteristics, widely utilized for a variety of industrial related to chlorophenols. applications. The conversion of an agricultural waste material into a useful commodity toward the removal of a potential contaminant seems to be an attractive way in economic as well * Corresponding author at: School of Chemical Sciences, Universiti as environmental point of view. Sains Malaysia, 11800 Penang, Malaysia. Tel.: +60 1126116051, +234 8039443335. Optimum conditions for AC preparation from PASH have E-mail address: [email protected] (Z.N. Garba). been reported in our earlier studies but no work has been Peer review under responsibility of University of Bahrain. reported to be done on the adsorption application of the http://dx.doi.org/10.1016/j.jaubas.2015.09.001 1815-3852 Ó 2015 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 18 A.A. Rahim, Z.N. Garba optimal PASH-AC on any type of adsorbate which constitutes pH (2–12) on the 4CG adsorption by PASH-AC and measured the novelty of our work. using a pH meter (Martini instrument, Mi 150). This work is therefore aimed at investigating the effect of Fourier Transform Infrared (FTIR) spectroscopy (FTIR- initial 4CG concentration, adsorption time and pH of the solu- 2000, PerkinElmer) with KBr technique was used in analysing tion on the optimal activated carbon (PASH-AC) using potas- the functional groups on the precursor as well as the PASH- sium oxalate (K2C2O4) as chemical activating agent for the AC surface. The spectra were documented from 4000 to removal of 4-Chloroguiacol (4CG). Kinetic, equilibrium data 400 cm 1. modeling as well as thermodynamics study of the spent PASH-AC were also investigated. Similar experiments were 3. Results and discussion carried out under the same conditions with commercial acti- vated carbon for comparison. 3.1. Characterization of PASH-AC
2. Materials and methods The spectra of precursor and PASH-AC in Fig. 1 show an increase and/or decrease of peaks. The broad bands between 2.1. Adsorbate (4-Chloroguiacol) 3500 and 3200 cm 1 on the spectra signify the presence of O–H or N–H functional groups, peaks between 3300– Sigma–Aldrich (M) Sdn Bhd, Malaysia supplied the adsorbate 3000 cm 1 and 3000–2800 cm 1 have been allotted to unsatu- (4CG) used with all the solutions prepared using deionized rated as well as saturated C–H respectively, those bands at water. 4CG has a molecular weight of 158.58 g/mol with chem- 1800–1600 cm 1, 1600–1700 cm 1 and 1500–1600 cm 1 were ical formula of C7H7ClO. for C‚O, C‚C or aromatic rings and C„N respectively (Shi et al., 2010). The bands between 1500 and 1400 cm 1 con- 2.2. Preparation of adsorbent (PASH-AC) note the presence of C–C stretching, additionally, the presence of C–O stretching in carboxyl acids, alcohols, phenols and Prosopis africana seed hulls (PASH) used as the precursor was esters was justified by the bands between 1260 and 1 collected from Nigeria. The procedure employed in producing 1050 cm . The weak peak located between 700 and 800 was the PASH-AC was as reported in our erstwhile work (Garba designated to C–OH (out of plane bending) in phenol. As and Afidah, 2014) where the precursor (PASH) was impreg- can be seen from the spectra, numerous functional groups van- ished after carbonization and activation processes. This was nated with the K2C2O4. The optimum preparation conditions applied were as obtained in our previous work (Garba and attributed to thermal degradation effect which resulted in the Afidah, 2014) which produced PASH-AC with reasonable destruction of some intermolecular bonding. yield and significant 4CG removal.
2.3. Removal of 4CG by batch adsorption
Batch adsorption experiments for the 4CG removal by PASH- AC were conducted as reported in our formerly published work (Garba et al., 2014). The 4CG percentage removed at equilibrium (%R) was evaluated as:
C C 4CG removal ð%Þ¼ o e 100 ð1Þ Co where the initial and equilibrium concentrations are denoted as Co and Ce (mg/L), respectively. The adsorbed equilibrium amount of 4CG, qe (mg/g), was estimated by Eq. (2):
ðC C ÞV q ¼ o e ð2Þ e W In order to analyze kinetics of the adsorption process, the 4CG concentration was evaluated at interludes of time. The 4CG amount adsorbed at time t, qt (mg/g) was evaluated using Eq. (3):
ðC C ÞV q ¼ o t ð3Þ t W The pH of the solution was adjusted with 0.1 M HCl and 0.1 M KOH solutions in order to study the effect of initial Figure 1 FT-IR spectra for (a) PASH and (b) PASH-AC. Adsorption of 4-Chloroguiacol from aqueous solution 19
3.2. Influence of adsorption time and 4CG concentrations
The influence of adsorption time on the 4CG removal by PASH-AC for six different adsorbate concentrations at 30 °C is described in Fig. 2. Rapid increase of the 4CG concentra- tions can be observed from the start, with much slower uptake following until equilibrium was established. Equilibrium position was attained at shorter time for lower initial concentrations than at higher initial concentrations as can be observed. The difference in equilibrium time attainment was attributed to the faster extinction or disappearance of adsorbate molecules at different initial concentrations (Hameed et al., 2008). The influence of potassium oxalate activating agent for the development of mesoporous and high surface area of PASH-AC with numerous functional groups as Figure 3 Effect of solution pH on 4CG removal by PASH-AC. seen in characterization results enhanced the faster adsorption process observed.
0 3.3. Effect of solution pH KLQaCe qe ¼ ð4Þ 1 þ KLCe Charge on adsorbent surface, functional group detachment on The isotherm constants associated with adsorption capacity its effective sites, the extent of ionization as well as structural 0 and rate of adsorption were symbolized as Qa (mg/g) and KL changes of adsorbate molecules can be influenced by solution (L/mg) respectively. Eq. (4) was expressed in five different lin- pH. As shown in Fig. 3, 4CG percentage removal shows a sig- ear forms, as tabulated in Table 1, with their major main dis- nificant decrease with an upsurge in the solution pH from 2 to parities connected to the distribution of data as well as the 12. The percentage removal, as high as 95.81% was achieved at parameter determination accuracy (Baccar et al., 2013). pH 2, which was attributed to its high tendency of hydrogen The term describing essential characteristics of the mono- bond formation with the surface of the PASH-AC due to the layer equation is referred to as dimensionless separation factor withdrawing group effect exerted by the methoxy group (RL), defined as (Sadaf et al., 2015): (Hamad et al., 2011). 1 RL ¼ ð5Þ 3.4. Adsorption isotherm modeling 1 þ KLCo
with Co standing for the highest 4CG initial concentration. Three most popular isotherm models (Temkin, Langmuir as Unfavorable adsorption is described by RL > 1, linear if well as Freundlich) were applied to probe the equilibrium data. RL = 1, favorable for 0, (0 < RL < 1) as well as irreversible Langmuir isotherm is one of the highly popular isotherms adsorption if RL =0. for the removal of dyes as well as other organic pollutants Second most widely used isotherm model is Freundlich iso- by adsorption onto activated carbon. The model is explained therm postulated base on surfaces that are heterogeneous. Its by Eq. (4) (Langmuir, 1916): logarithmic form is expressed as (Freundlich, 1906): 1 log q ¼ log K þ log C ð6Þ e F n e
with the two constants symbolized as KF and n measuring the adsorption capacity of the adsorbent as well as how the model
Table 1 Linear forms of Langmuir isotherm. Isotherm Linear form Plot Langmuir-1 1 1 1 1 1 ¼ o þ o vs qe KLQaCe Qa qe Ce Langmuir-2 Ce Ce 1 Ce ¼ o þ o vs Ce qe Qa KLQa qe Langmuir-3 qe o qe qe ¼ þ Qa qevs KLCe Ce Langmuir-4 qe o qe ¼ KLqe þ KLQa vs qe Ce Ce o Langmuir-5 1 KLQa 1 1 ¼ KL vs Figure 2 Effect of contact time on 4CG adsorption onto PASH- Ce qe Ce qe AC at various initial concentrations. 20 A.A. Rahim, Z.N. Garba deviates from linearity, respectively. Generally, n > 1 suggests five linear equations were not the same as can be observed favorable adsorption of adsorbate on the adsorbent. The from Table 2, because the transformations change the original greater the value of n, the more sturdy the adsorption strength. error distribution (Baccar et al., 2013). Based on the R2 values, Temkin model was based on how indirect adsorbent/adsor- the best fit should have been Langmuir-1 or Langmuir-5 iso- bate interactions influence the adsorption isotherms. Its linear therms in comparison with the other isotherm equations form is expressed as (Temkin and Pyzhev, 1940): because they showed the largest values (R2 = 0.9986). 2 RT RT But according to Baccar et al. (2013) the highest R does qe ¼ ln A þ lnCe ð7Þ not necessarily describe the most superlative transformation. b b So as observed from Table 2, Langmuir-1 and 5 had the high- RT 2 2 2 where b = B (J/mol) and A (L/g) are Temkin constants, est R values (R = 0.9986) but their v values (1.130) were which are related to heat of sorption and maximum binding also larger, higher than Langmuir-2 (0.234), therefore they energy, respectively, R is the gas constant (8.31 J/mol K) and cannot be concluded to perfectly describe the equilibrium data. T (K) is the absolute temperature. It can also be seen from Table 2 that v2 value of the Langmuir- To compare the validity of each model, chi square (v2) was 2 isotherm (0.234) was lower than those obtained from the Fre- incorporated since correlation coefficient (R2) may not justify undlich (0.759) and Temkin (59.859), therefore, the maximum the basis for selecting the best adsorption model because it 0 ; adsorption capacity (QaÞ sorption energy (KL) and separation only signifies the fit between linear forms of the isotherm equa- factor (RL) values of 498.67 mg/g, 0.038 and 0.069, respectively tions and experimental data and while the suitability between were adopted from the Langmuir-2 equation. experimental and predicted values of the adsorption capacity The high Q0 of 498.67 mg/g observed in this study was v2 v2 a is described by chi square ( ). The lower the value, the bet- attributed to the relatively high surface area of the PASH- ter the fit. AC and its mesoporous structure (Garba and Afidah, 2014). Table 2 summarizes the parameters obtained from the 2 It compares well with those obtained from the literature as adsorption isotherm models applied with their respective R summarized in Table 3. and v2 values. The Langmuir parameters obtained from the 3.5. Adsorption kinetic studies
The kinetics of 4CG adsorption was investigated by applying Table 2 Langmuir (1–5), Freundlich and Temkin isotherm Lagergren pseudo-first order and pseudo-second order (1 and model parameter correlation coefficients and chi square values 2) models. The pseudo-first-order linear equation was given for 4CG adsorption on PASH-AC at 30 °C. as (Lagergren and Svenska, 1898): k Isotherm Parameters q q q 1 t logð e tÞ¼log e : ð8Þ 0 R R2 v2 2 303 Qa (mg/g) L where k is the pseudo-first-order rate constant (h 1). Langmuir 1 Langmuir-1 407.29 0.054 0.9986 1.130 The two linear forms of pseudo-second-order equations Langmuir-2 498.67 0.069 0.9957 0.234 were expressed as Eqs. (9) and (10): Langmuir-3 481.57 0.067 0.9792 8.728 t 1 1 ¼ þ t ð9Þ Langmuir-4 493.09 0.055 0.9792 1.420 q k q2 q Langmuir-5 413.59 0.055 0.9986 2.860 t 2 e e K (mg/g (L/mg) nR2 v2 1 1 1 1 F 10 ¼ 2 þ ð Þ Freundlich 2.3276 1.382 0.9904 0.759 qt k2qe t qe 2 2 A (L/g) B (J/mol) R v where k2 (g/mgh) is the pseudo-second-order rate constant. 2 v2 Temkin 0.644 85.518 0.9470 59.859 The values of qe, k1, R and obtained after the linear 2 2 plots of Eq. (8) and qe, k2, R and v from the plots of Eqs.
Table 3 Comparison of maximum monolayer adsorption capacity of various CPs on different adsorbents.
0 Adsorbent Adsorbate Qa (mg/g) References PASH-AC 4-Chloroguaiacol 498.67 This work Commercial activated carbon 4-Chloroguaiacol 276.88 This study Oil palm shell activated carbon 4-Chloroguaiacol 454.45 Hamad et al. (2010) Oil palm shell activated carbon 4-chloro2-methoxy phenol 323.62 Hamad et al. (2011) Rattan sawdust based activated carbon 4-chlorophenol 188.68 Hameed et al. (2008) Cattail fibre-based activated carbon 2,4-Dichlorophenol 142.86 Ren et al. (2011) Rice straw carbon 3-chlorophenol 14.2 Wang et al. (2007) Adsorption of 4-Chloroguiacol from aqueous solution 21
Table 4 Pseudo-first-order and pseudo-second-order (1 and 2) kinetic model parameters of 4CG adsorption on PASH-AC at 30 °C.
Co (mg/L) qe,exp (mg/g) Pseudo-first-order Pseudo-second-order-1 Pseudo-second-order-2 2 2 2 2 2 2 k1 (1/h) qe,cal (mg/g) R v k2 (g/mg h) qe,cal (mg/g) R v k2 (g/mg h) qe,cal (mg/g) R v 30 28.51 0.330 14.73 0.981 0.234 0.100 26.88 0.996 0.003 0.178 24.57 0.960 0.019 60 56.60 0.482 41.21 0.989 0.074 0.023 59.52 0.997 0.003 0.029 55.87 0.998 0.001 100 93.81 0.377 57.73 0.988 0.148 0.021 90.91 0.992 0.001 0.037 81.97 0.969 0.016 150 139.31 0.430 89.78 0.997 0.126 0.013 138.89 0.993 0.009 0.026 120.48 0.958 0.018 250 228.38 0.356 134.15 0.978 0.170 0.010 217.39 0.995 0.002 0.016 200.00 0.972 0.015 350 307.86 0.421 215.48 0.990 0.090 0.005 312.50 0.996 0.002 0.0064 285.71 0.991 0.005
of these kinetic models in describing the 4CG adsorption pro- cess, chi-square (v2) statistical analysis was also applied. As can be observed from Table 4, the v2 values acquired from both the pseudo-second-order 1 and 2 models (0.001–0.019) were lower than those obtained from the pseudo-first-order (0.074–0.234) which further confirms the pseudo-second- order equation to be the most preeminent kinetic model in describing the 4CG adsorption onto PASH-AC. The kinetic models were limited in terms of identifying the diffusion mechanisms as well as the rate controlling steps in the adsorption process, as result of that limitation; intraparticle diffusion model was further applied. The intraparticle diffu- sion equation is expressed as:
1=2 Figure 4 Plot of intraparticle diffusion model for adsorption of qt ¼ kipt þ C ð11Þ 4CG onto PASH-AC at 30 °C. where kip is rate constant of the intra-particle diffusion equa- tion and C gives information about the boundary layer thick- ness: larger value of C is associated with the boundary layer 1/2 (9) and (10) (figures not shown) for the 4CG adsorption on the diffusion effect. When the linear plot qt versus t is linear PASH-AC are reported in Table 4. and passes through the origin, it connotes that the adsorption As can be observed from Table 4, the trends of R2 values process follows the intraparticle diffusion model, and that the (0.981–0.997) for the pseudo-first-order model were not coher- only rate limiting step involved is intraparticle diffusion, if not, ent. Also, the calculated and experimental qe values were not in then it connotes that intraparticle diffusion is not the only rate good concord with each other, indicating the inappropriate- limiting step involved (Fan et al., 2011). ness of pseudo first-order kinetic model in describing 4CG The intraparticle diffusion plots for the adsorption of 4CG adsorption onto PASH-AC. However, the harmony between on PASH-AC at 30 °C are depicted by Fig. 4. experimental and calculated qe values obtained from pseudo- As can be seen from Fig. 4, a very rapid adsorption was second-order (1 and 2) models were lofty with all the R2 values described by the first sharper region completed attributed to obtained very near to unity, confirming that the most suitable a strong electrostatic attraction between 4CG and the model to describe 4CG adsorption onto PASH-AC was PASH-AC external surface. The next stage describes a steady pseudo-second-order model. To further confirm the suitability adsorption stage, which can be attributed to intraparticle
Table 5 Intraparticle diffusion model parameters for the adsorption of 4CG onto PASH-AC.
Co (mg/L) Intraparticle diffusion model 1/2 1/2 2 2 kp2 (mg/g h ) kp3 (mg/g h ) C2 C3 (R2) (R3) 30 6.847 – 11.007 25.750 0.9561 – 60 20.593 0.2227 9.692 52.633 0.9534 0.4919 100 26.770 0.5229 27.354 87.648 0.9660 0.4919 150 42.560 0.2742 37.794 135.630 0.9835 0.4919 250 64.115 – 69.124 – 0.9498 – 350 106.980 – 55.924 – 0.9639 – 22 A.A. Rahim, Z.N. Garba
upsurge in both adsorption time as well as initial 4CG concen- Table 6 Thermodynamic parameters for the adsorption of tration. The adsorption process was more promising in lower 4CG onto PASH-AC at different temperatures. pH solution with the Langmuir-2 model being the most appro- DH (kJ/mol) DS (J/mol K) DG (kJ/mol) priate in describing the equilibrium data. The kinetics data 303 K 313 K 323 K obeyed pseudo-second-order model. 4CG adsorption onto PASH-AC was primarily presided by particle diffusion 1.49 24.30 5.94 5.96 6.43 according to the Boyd plot. The positive DH values observed connoted the adsorption process to be endothermic. The adsorption potential of the PASH-AC competed satisfactorily diffusion of the 4CG molecule through the activated carbon’s with earlier studied adsorbents. Based on the obtained results, pores. Third stage exists in few cases, especially when the 4CG the PASH-AC produced can be used effectively to tackle pol- initial concentrations are high. At that stage, the intraparticle lution problems posed by chloroguaicols in the environment. diffusion starts to slow down (Wang et al., 2010). 2 The values of kpi, Ci and R obtained are given in Table 5. Acknowledgement The values of kp2 as can be seen from Table 5 increased with upsurge in the initial 4CG concentration, which was attributed Research University Grant 1001/PKIMIA/854002 from to the greater driving force. The values of C2 and C3 also Universiti Sains Malaysia that ensued in this article was recog- increased with the increase in 4CG concentration from 30 to nized by the authors. 350 mg/L signifying an increase in the thickness of the bound- ary layer (Khaled et al., 2009). References In the second and third stages as can be observed from Fig. 4, the linear lines did not pass through the origin which Baccar, R., Bla´ nquez, P., Bouzid, J., Feki, M., Attiya, H., Sarra` , M., suggested the presence of intraparticle diffusion along with 2013. Modeling of adsorption isotherms and kinetics of a tannery possibility of involvement of some other rate controlling steps dye onto an activated carbon prepared from an agricultural by- in the adsorption process (Maksin et al., 2012). product. Fuel Process. Technol. 106, 408–415. El Haddad, M., Mamouni, R., Saffaj, N., Lazar, S., 2012. Removal of 3.6. Adsorption thermodynamic studies a cationic dye – Basic Red 12 – from aqueous solution by adsorption onto animal bone meal. J. Assoc. Arab Univ. Basic Appl. Sci. 12, 48–54. D D Gibb’s free energy change ( G), enthalpy change ( H) and El Haddad, M., Slimani, R., Mamouni, R., ElAntri, S., Lazar, S., entropy change (DS) are the most popular thermodynamic 2013. Removal of two textile dyes from aqueous solutions parameters that were considered and studied in this work. Van’t onto calcined bones. J. Assoc. Arab Univ. Basic Appl. Sci. 14, Hoff equation was employed in determining the thermodynamic 51–59. parameters which was expressed as (Slimani et al., 2014): Fan, J., Zhang, J., Zhang, C., Ren, L., Shi, Q., 2011. Adsorption of 2,4,6-trichlorophenol from aqueous solution onto activated carbon DS DH ln KD ¼ ð12Þ derived from loosestrife. Desalination 267, 139–146. R RT Freundlich, H.M.F., 1906. Over the adsorption in solution. J. Phys. where R (8.314 kJ/mol) is the universal gas constant; T (K) is Chem. 57, 385–470. qe Galadima, A., Garba, Z.N., Leke, L., Almustapha, M.N., Adam, I.K., the absolute temperature; KD ¼ is the distribution coeffi- Ce 2011. Domestic water pollution among local communities in cient; qe (mg/g) is the amount of adsorbate adsorbed on the nigeria––causes and consequences. Eur. J. Sci. Res. 52 (4). sorbent per unit mass. A linear plot of lnK against 1/T gives D Garba, Z.N., Afidah, A.R., 2014. Process optimization of K2C2O4- a graph (Fig. not shown) with DH and DS obtained from the activated carbon from Prosopis africana seed hulls using response slope and intercept respectively. DG was evaluated from the surface methodology. J. Anal. Appl. Pyrol. 107, 306–312. relation below: Garba, Z.N., Afidah, A.R., Hamza, S.A., 2014. Potential of borassus aethiopum shells as precursor for activated carbon preparation by DG RT ln K 13 ¼ D ð Þ physico-chemical activation; optimization, equilibrium and kinetic The thermodynamic parameters obtained for the adsorp- studies. J. Environ. Chem. Eng. 2, 1423–1433. tion of the 4CG on PASH-AC at three different temperatures Hamad, B.K., Noor, A.M., Afida, A.R., Mohd Asri, M.N., 2010. High are reported in Table 6. removal of 4-chloroguaiacol by high surface area of oil palm shell- activated carbon activated with NaOH from aqueous solution. Positive values were obtained for both DH and DS, implying Desalination 257 (1–3), 1–7. that the 4CG adsorption process was endothermic with random Hamad, B.K., Ahmad, M.N., Afidah, A.R., 2011. Removal of 4- characteristics. The Gibb’s free energy of change was sponta- chloro-2-methoxy phenol by adsorption from aqueous solution D neous as can be seen by the negative values obtained. The G using oil palm shell carbon activated by K2CO3. J. Phys. Sci. 22, values also confirmed the adsorption of 4CG onto PASH-AC 41–58. to be a physical process with the physical adsorption values Hameed, B.H., Chin, L.H., Rengaraj, S., 2008. Adsorption of 4- ranging from 20 to 0 kJ/mol while value from 80 to chlorophenol onto activated carbon prepared from rattan sawdust. 400 kJ/mol describes chemical adsorption (Li et al., 2010). Desalination 225 (1–3), 185–198. Jodeh, S., Abdelwahab, F., Jaradat, N., Warad, I., Jodeh, W., 2016. Adsorption of diclofenac from aqueous solution using Cyclamen 4. Conclusions persicum tubers based activated carbon (CTAC). J. Assoc. Arab Univ. Basic Appl. Sci. 20, 32–38. PASH-AC was produced from Prosopis africana seed hulls. Its Khaled, A., El-Nemr, A., El-Sikaily, A., Abdelwahab, O., 2009. adsorption capacity was observed to be increasing with an Removal of Direct N Blue106 from artificial textile dye effluent Adsorption of 4-Chloroguiacol from aqueous solution 23
using activated carbon from orange peel: adsorption isotherm and Ren, L., Zhang, J., Li, Y., Zhang, C., 2011. Preparation and evaluation kinetic studies. J. Hazard. Mater. 165, 100–110. of cattail fiber-based activated carbon for 2,4-dichlorophenol and Lagergren, S., Svenska, B.K., 1898. On the theory of so-called 2,4,6-trichlorophenol removal. Chem. Eng. J. 168, 553–561. adsorption of dissolved substances. R. Swed. Acad. Sci. Doc. 24, Sadaf, S., Bhatti, H.N., Nausheen, S., Amin, M., 2015. Removal of Cr 1–13. (VI) from wastewater using acid-washed zero-valent iron catalyzed Langmuir, I., 1916. The constitution and fundamental properties of by polyoxometalate under acid conditions: efficacy, reaction solids and liquids part I solids. J Am. Chem. Soc. 38, mechanism and influencing factors. J. Taiwan Inst. Chem. Eng. 2221–2295. 47, 160–170. Li, Q., Yue, Q., Su, Y., Gao, B., Sun, H., 2010. Equilibrium, Shi, Q.Q., Zhang, J., Zhang, C.L., Li, C., Zhang, B., Hu, W.W., Xu, J. thermodynamics and process design to minimize adsorbent amount T., 2010. Preparation of activated carbon from cattail and its for the adsorption of acid dyes onto cationic polymer-loaded application for dyes removal. J. Environ. Sci. 22, 91–97. bentonite. Chem. Eng. J. 158, 489–497. Slimani, R., El Ouahabi, I., Abidi, F., El Haddad, M., Regti, A., Maksin, D.D., Nastasovic´ , A.B., Milutinovic´ -Nikolic´ , A.D., Surucˇ ic´ , Laamari, M., El Antri, S., Lazar, S., 2014. Calcined eggshells as a L.T., Sandic´ , Z.P., Hercigonja, R.V., Onjia, A.E., 2012. Equilib- new biosorbent to remove basic dye from aqueous solutions: rium and kinetics study on hexavalent chromium adsorption onto thermodynamics, kinetics, isotherms and error analysis. J. Taiwan diethylene triamine grafted glycidyl methacrylate based copoly- Inst. Chem. Eng. 45, 1578–1587. mers. J. Hazard. Mater. 209, 99–110. Temkin, M.J., Pyzhev, V., 1940. Recent modifications to Langmuir Noreen, S., Bhatti, H.N., 2014. Fitting of equilibrium and kinetic data isotherms. Acta Physicochim. 12, 217–222. for the removal of Novacron Orange P-2R by sugarcane bagasse. J. Wang, S.L., Tzou, Y.M., Lu, Y.H., Sheng, G., 2007. Removal of 3- Ind. Eng. Chem. 20, 1684–1692. chlorophenol from water using rice-straw-based carbon. J. Hazard. Noreen, S., Bhatti, H.N., Nausheen, S., Sadaf, S., Ashfaq, M., 2013. Mater. 147, 313–318. Batch and fixed bed adsorption study for the removal of Drimarine Wang, L., Zhang, J., Zhao, R., Li, C., Li, Y., Zhang, C., 2010. Black CL-B dye from aqueous solution using a lignocellulosic Adsorption of basic dyes on activated carbon prepared from waste: a cost affective adsorbent. Ind. Crops Prod. 50, Polygonum orientale Linn: equilibrium, kinetic and thermody- 568–579. namic studies. Desalination 254, 68–74. Journal of the Association of Arab Universities for Basic and Applied Sciences (2016) 21,24–30
University of Bahrain Journal of the Association of Arab Universities for Basic and Applied Sciences www.elsevier.com/locate/jaaubas www.sciencedirect.com
ORIGINAL ARTICLE A thermodynamical, electrochemical and surface investigation of Bis (indolyl) methanes as Green corrosion inhibitors for mild steel in 1 M hydrochloric acid solution
Chandrabhan Verma, Pooja Singh, M.A. Quraishi *
Department of Chemistry, Indian Institute of Technology, Banaras Hindu University, Varanasi 221005, India
Received 23 February 2015; revised 20 April 2015; accepted 25 April 2015 Available online 23 May 2015
KEYWORDS Abstract The influence of three Bis (indolyl) methanes (BIMs) namely, 3,30-((4-nitrophenyl) methy- 0 Mild steel; lene) bis (1H-indole) (BIM-1), 3,3 -(phenyl methylene) bis (1H-indole) (BIM-2) and 4-((1H-indol-2- Corrosion; yl)(1H-indol-3-yl) methyl) phenol (BIM-3) on the mild steel corrosion in 1 M HCl was studied by EIS; weight loss, electrochemical, scanning electron microscopy (SEM), and dispersive X-ray spec- Tafel polarization; troscopy (EDX) methods. Results showed that BIM-3 shows maximum inhibition efficiency of SEM/EDX 98.06% at 200 mg L 1 concentration. Polarization study revealed that the BIMs act as mixed type inhibitors. Adsorption of BIMs on the mild steel surface obeyed the Langmuir adsorption isotherm. The weight loss and electrochemical results were well supported by SEM and EDX studies. ª 2015 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction procedure, high yield, high selectivity and clean reaction (Joshi et al., 2010). Organic compounds particularly, N-heterocyclic have been Indole and its derivatives have received considerable atten- reported as effective corrosion inhibitors for mild steel against tion of synthetic chemists due to their several biological appli- corrosion during several industrial processes (Solmaz, 2014; cations such as antibacterial, cytotoxic, antioxidative, Musa et al., 2012; Mahdavian and Ashhari, 2010; Ozkir insecticidal activities and bioactive metabolites of terrestrial et al., 2012). Ultrasound irradiation has immerged as a power- and marine origin (Surasani et al., 2013). In our present inves- ful technique for the synthesis of various heterocyclic com- tigation we have synthesized and studied the corrosion inhibi- pounds of industrial and biological interest (Goharshad tion efficiency of three Bis (indolyl) methanes on mild steel et al., 2009) due to their shorter reaction time, simple operating corrosion in 1 M HCl. The criteria behind selecting these com- pounds as corrosion inhibitors were that: (a) they can be easily * Corresponding author. Tel.: +91 9307025126; fax: +91 542 synthesized from commercially available and relatively cheap 2368428. starting materials (b) contain –OH, –NO2 and hetero- E-mail addresses: [email protected], maquraishi@ aromatic rings through which they can adsorb and inhibit cor- rediffmail.com (M.A. Quraishi). rosion (c) they were effective even at low concentration and (d) Peer review under responsibility of University of Bahrain. they were highly soluble in testing medium. Previously, few http://dx.doi.org/10.1016/j.jaubas.2015.04.003 1815-3852 ª 2015 University of Bahrain. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Investigation of Bis (indolyl) methanes as Green corrosion inhibitors 25 authors reported the corrosion inhibition efficiency of the 2.4. Electrochemical experiments indole and its derivatives in acid solution for different metals (Norr, 2008; Popova and Christov, 2006; Lowmunkhong As described earlier (Verma et al., 2014a), a typical three elec- et al., 2010; Quartarone et al., 2008). trodes glass cell consisting of a highly pure platinum mesh as counter electrode, a saturated calomel as reference electrode 2. Experimental section and mild steel specimen as working electrode was used for elec- trochemical studies. The Tafel and EIS measurements were 2.1. Material carried out using a Gamry Potentiostat/Galvanostat (Model G-300) with EIS Software Gamry Instruments Inc., USA. The mild steel specimens having composition (wt.%): Echem Analyst 5.0 Software package was applied to analyze C = 0.076, Mn = 0.192, P = 0.012, Si = 0.026, Cr = 0.050, the electrochemical data. The cathodic and anodic Tafel slopes Al = 0.023, and remainder Fe were used in present study. were recorded by changing the electrode potential inevitably The test solution (1 M HCl) was prepared by dilution of ana- from 0.25 to +0.25 V vs. corrosion potential (Ecorr) at a con- 1 lytical grade HCl (MERK, 37%) in double deionized water. stant sweep rate of 1.0 mV s . The EIS studies were carried out under potentiostatic condition in a frequency range of 2.2. Synthesis of inhibitors (BIMs) 100 kHz–0.01 Hz. The amplitude of the AC sinusoid wave was 10 mV. All the Tafel and EIS studies were performed in naturally aerated solution of 1 M HCl in the absence and the In the present study Bis (indolyl) methanes (BIMs) were synthe- presence of 200 mg L 1 concentration of BIMs after 30 min sized as described earlier (Sonar et al., 2009). The synthetic rout immersion time. for BIMs is shown in Scheme 1. The purity of products was determined by TLC method. The characterization data of the 2.5. SEM/EDX analysis synthesized compounds are as follows: BIM-1 (3,30-((4- nitrophenyl) methylene) bis (1H-indole, –R = –Ph (4-NO2))): MP: 223-224 C, IR (KBr, cm 1): 3428, 2829, 2245, 1680–1660, The SEM model Ziess Evo 50XVP instrument was used for the 1522, 1230, 845, 739, 641. BIM-2 (3,30-(phenyl methylene) bis mild steel surface analysis with and without BIMs using accel- (1H-indole) –R = Ph): MP: 125–127 C, IR (KBr, cm 1): erating voltage of 50 kV at 500· magnifications. Before SEM 3465, 2811, 2275, 1482, 1130, 825, 758, 611. BIM-3 (4-((1H- and EDX analysis the mild steel samples were immersed for indol-2-yl)(1H-indol-3-yl) methyl) phenol, –R = Ph(4-OH)): 3 h in the absence and the presence of BIMs. The elemental MP: 123–125 C, IR (KBr, cm 1): 3623, 3475, 2831, 2356, composition was determined using energy dispersive X-ray 1453, 1238, 845, 734, 623. spectroscopy (EDX) coupled with SEM.
2.3. Gravimetric experiment 3. Result and discussion
The weight loss experiments in the absence and the presence of 3.1. Weight loss measurements different concentrations of BIMs were carried out to optimize the concentration of BIMs as described earlier (Verma et al., 3.1.1. Effect of concentration 2014). The corrosion rate (CR), percentage inhibition efficiency Variation of the inhibition efficiency (g%) at different studied (g%) and surface coverage (h) were calculated using following concentrations of BIMs is shown in Fig. 1. It is obvious that equations. 87:6W C ¼ ð1Þ R Atd C C g% ¼ R RðiÞ 100 ð2Þ CR C C h ¼ R RðiÞ ð3Þ CR where, W is the weight loss in mg, A is the area (cm2) of the mild steel sample exposed to 1 M HCl, t is the immersion time 3 (3 h), d is the density of mild steel (g cm ) and CR and CR(i) are the corrosion rates in the presence and the absence of BIMs, respectively.
H N
H N O Alum (10%) + 2 Solvenr free, US R R H
H NH Figure 1 Variation of inhibition efficiency with BIMs concen- BIM-1: R = -Ph(4-NO2), BIM-2: R = -Ph, BIM-3: R = -Ph (4-OH) tration of mild steel immersed in 1 M HCl obtained by weight loss Scheme 1 Synthetic route for investigated BIMs. measurement. 26 C. Verma et al. the values of g% increases on increasing BIMs concentration. 3.1.2. Effect of temperature 1 The maximum g% was obtained at 200 mg L concentration To investigate the effect of temperature on inhibition perfor- further increase in concentration does not cause any significant mance of BIMs, the weight loss experiments were also per- change in the inhibition performance suggesting that formed at different temperatures (308–338 K). The values of 200 mg L 1 is the optimum concentration. The increase in the CR at different studied temperatures are listed in Table 1. BIMs concentration increases the surface coverage (h) through It is apparent from results that the value of the CR increases adsorbing on its surface and therefore, increases inhibition effi- on increasing temperature for inhibited as well as uninhibited ciency (Yadav et al., 2013). solutions. This increased values of CR is attributed to desorp- tion of the adsorb BIMs molecules from mild steel surface at elevated temperatures, resulting in enhanced CR (Barmatov et al., 2015). Table 1 Variation of corrosion rate with temperature in the The temperature dependency of corrosion rate can be best absence and presence of optimum concentration of BIMs. represented by the Arrhenius and transition state equations